ID	Title	Country	Ctl	MA	Type	Drugs	Primary Endpoint	Population	
<a href="https://ClinicalTrials.gov/show/NCT04319900">NCT04319900</a>	Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia	China	Y	Y	Drug Repurposing	Favipiravir, Chloroquine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04252885">NCT04252885</a>	The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection	China	Y	Y	Drug Repurposing	Lopinavir/ritonavir, Umifenovir	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04282902">NCT04282902</a>	A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection	China	Y	N	Drug Repurposing	Pirfenidone	Efficacy - Oxygen parameters	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04329520">NCT04329520</a>	EPICOS Clinical Trial for the Prevention of Infection in Healthcare Personnel	Spain	Y	Y	Drug Repurposing	Emtricitabine/tenofovir, Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04337216">NCT04337216</a>	Mavrilimumab to Reduce Progression of Acute Respiratory Failure in Patients With Severe COVID-19 Pneumonia and Systemic Hyper-inflammation	United States	N	N	Shelved drug or NME	Mavrilimumab	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001224-33/DE">2020-001224-33</a>	Randomized controlled trial of hydroxychloroquine versus placebo for the treatment of adult patients with acute coronavirus disease 2019 &ndash; COVID-19	Germany	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49607">ChiCTR2000029935</a>	A Single-arm Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19)	China	N	N	Drug Repurposing	Chloroquine	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49533">ChiCTR2000029850</a>	Effecacy and safty of convalescent plasma treatment for severe patients with novel coronavirus pneumonia (COVID-19): a prospective cohort study	China	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Mortality	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49342">ChiCTR2000029776</a>	A randomized, open-label, blank-controlled, multicenter trial for Polyinosinic-Polycytidylic Acid Injection in the treatment of novel coronavirus pneumonia (COVID-19)	China	N	N	Shelved drug or NME	Polyinosinic-Polycytidylic Acid	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49086">ChiCTR2000029656</a>	A randomized, open-label study to evaluate the efficacy and safety of low-dose corticosteroids in hospitalized patients with novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Methylprednisolone	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49297">ChiCTR2000029742</a>	A randomized, parallel controlled trial for the efficacy and safety of Sodium Aescinate Injection in the treatment of patients with pneumonia (COVID-19)	China	Y	N	Shelved drug or NME	Sodium Aescinate	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49263">ChiCTR2000029741</a>	Efficacy of Chloroquine and Lopinavir/ Ritonavir in mild/general novel coronavirus (CoVID-19) infections: a prospective, open-label, multicenter randomized controlled clinical study	China	Y	N	Drug Repurposing	Chloroquine	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49215">ChiCTR2000029636</a>	Efficacy and safety of aerosol inhalation of vMIP in the treatment of novel coronavirus pneumonia (COVID-19): a single arm clinical trial	China	N	N	Shelved drug or NME	vMIP	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49161">ChiCTR2000029806</a>	Optimization of treatment and diagnosis plan for critically ill patients	China	Y	Y	Drug Repurposing, Shelved drug or NME	Thymosin, Camrelizumab	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49612">ChiCTR2000029939</a>	A Single-blind, Randomized, Controlled Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19)	China	Y	N	Drug Repurposing	Chloroquine	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49409">ChiCTR2000029765</a>	A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Tocilizumab	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49062">ChiCTR2000029569</a>	Safety and efficacy of umbilical cord blood mononuclear cells conditioned medium in the treatment of severe and critically novel coronavirus pneumonia (COVID-19): a randomized controlled trial	China	Y	N	Shelved drug or NME	ND:MSC	Efficacy - Other efficacy	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=48968">ChiCTR2000029542</a>	A prospective cohort study for the efficacy and safety of chloroquine in hospitalized patients with novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Chloroquine	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=48991">ChiCTR2000029539</a>	A randomized, open-label study to evaluate the efficacy and safety of Lopinavir-Ritonavir in patients with mild novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Lopinavir/ritonavir	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49229">ChiCTR2000030173</a>	Key techniques of umbilical cord mesenchymal stem cells for the treatment of novel coronavirus pneumonia (COVID-19) and clinical application demonstration	China	Y	N	Cell/Blood based	ND:MSC	Efficacy - Oxygen parameters	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49901">ChiCTR2000030116</a>	Safety and effectiveness of human umbilical cord mesenchymal stem cells in the treatment of acute respiratory distress syndrome of severe novel coronavirus pneumonia (COVID-19)	China	N	N	Cell/Blood based	ND:MSC	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49042">ChiCTR2000029600</a>	Clinical study on safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19)	China	Y	Y	Drug Repurposing	Favipiravir, Lopinavir/ritonavir, Interferon alpha	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49532">ChiCTR2000029853</a>	A randomized, open-label, controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)	China	Y	N	Shelved drug or NME	Azvudine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=48880">ChiCTR2000029559</a>	Therapeutic effect of hydroxychloroquine on novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49013">ChiCTR2000029544</a>	A randomized controlled trial for the efficacy and safety of Baloxavir Marboxil, Favipiravir tablets in novel coronavirus pneumonia (COVID-19) patients who are still positive on virus detection under the current antiviral therapy	China	Y	Y	Drug Repurposing	Baloxavir Marboxil, Favipiravir	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=48992">ChiCTR2000029541</a>	A randomised, open, controlled trial for darunavir/cobicistat or Lopinavir/ritonavir combined with thymosin a1 in the treatment of novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Darunavir, Cobicistat, Lopinavir/ritonavir, Thymosin alpha	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=48919">ChiCTR2000029468</a>	The early use of lopinavir/litonavir (LPV/r) and emtritabine (FTC)/ Tenofovir alafenamide Fumarate tablets (TAF) regimen in the treatment of the novel coronavirus pneumonia (COVID-19): a real-world study	China	Y	N	Drug Repurposing	Lopinavir/ritonavir, Emtricitabine, Tenofovir alafenamide	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49567">ChiCTR2000030167</a>	Clinical Trial for Recombinant Human Interleukin-2 in the Treatment of Novel Coronavirus Pneumonia (COVID-19)	China	Y	N	Drug Repurposing	recombinant human IL-2	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49145">ChiCTR2000029609</a>	A prospective, open-label, multiple-center study for the efficacy of chloroquine phosphate in hospitalized patients with novel coronavirus pneumonia (COVID-19)	China	Y	Y	Drug Repurposing	Chloroquine, Lopinavir/ritonavir	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49146">ChiCTR2000029606</a>	Clinical Study for Human Menstrual Blood-derived Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19)	China	Y	N	Cell/Blood based	ND:MSC	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49831">ChiCTR2000030058</a>	A multicenter, randomized, double-blind, controlled clinical trial for leflunomide in the treatment of novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Leflunomide	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49891">ChiCTR2000030041</a>	A single-arm, single-center clinical trial for Azivudine tablets in the treatment of adult novel coronavirus pneumonia (COVID-19)	China	N	N	Shelved drug or NME	Azvudine	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50059">ChiCTR2000030179</a>	Experimental study of novel coronavirus pneumonia rehabilitation plasma therapy severe novel coronavirus pneumonia (COVID-19)	China	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49988">ChiCTR2000030113</a>	Clinical study for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19) with poorly responsive ritonavir/ritonavir	China	Y	N	Drug Repurposing	Favipiravir	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49799">ChiCTR2000030016</a>	Efficacy evaluation of inhalation of mycobacterium vaccae injection for treating Novel coronavirus pneumonia (COVID-19) and the mechanism study of prevention and treatment of respiratory virus infection	China	Y	N	Shelved drug or NME	Mycobacterium vaccae	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49861">ChiCTR2000030046</a>	A single arm trial to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in the treatment of novel coronavirus pneumonia patient (COVID-19)	China	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49619">ChiCTR2000030007</a>	Multicenter randomized controlled trial for rhG-CSF in the treatment of novel coronavirus pneumonia (COVID-19)	China	Y	N	Cell/Blood based	G-CSF	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49824">ChiCTR2000030029</a>	A multi-center study on the efficacy and safety of suramin sodium in adult patients with novel coronavirus pneumonia (COVID-19)	China	N	N	Drug Repurposing	Suramin	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49723">ChiCTR2000030001</a>	The efficacy and safety of Triazavirin for 2019 novel coronary pneumonia (COVID-19): a multicenter, randomized, double blinded, placebo-controlled trial	China	Y	N	Shelved drug or NME	Triazavirin	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49777">ChiCTR2000030010</a>	A randomized, double-blind, parallel-controlled, trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia patients (COVID-19)	China	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50017">ChiCTR2000030170</a>	Study for safety and efficacy of Jakotinib hydrochloride tablets in the treatment severe and acute exacerbation patients of novel coronavirus pneumonia (COVID-19)	China	N	N	Shelved drug or NME	Jaktinib	Safety	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50004">ChiCTR2000030138</a>	Clinical Trial for Human Mesenchymal Stem Cells in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19)	China	Y	N	Shelved drug or NME	ND:MSC	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49510">ChiCTR2000029996</a>	A randomized, open-label, controlled trial for the efficacy and safety of Farpiravir Tablets in the treatment of patients with novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Favipiravir	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49674">ChiCTR2000029990</a>	Clinical trials of mesenchymal stem cells for the treatment of pneumonitis caused by novel coronavirus (COVID-19)	China	Y	N	Shelved drug or NME	ND:MSC	Efficacy - Oxygen parameters	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49534">ChiCTR2000029851</a>	A multicenter, randomized controlled trial for the efficacy and safety of Alpha lipoic acid (iv) in the treatment of patients of severe novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Alpha Lipoic Acid	Efficacy - Other efficacy	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49889">ChiCTR2000030089</a>	A randomized, open-label, controlled trial for the efficacy and safety of  Adalimumab Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Adalimumab	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49428">ChiCTR2000029803</a>	A prospective, randomized, open-label, controlled clinical study to evaluate the preventive effect of hydroxychloroquine on close contacts after exposure to the Novel Coronavirus Pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Hydroxychloroquine, Umifenovir	Efficacy - Infection rate (prevention)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49902">ChiCTR2000030088</a>	Umbilical cord Wharton's Jelly derived mesenchymal stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19)	China	Y	N	Cell/Blood based	ND:MSC	Efficacy - Viral load	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49317">ChiCTR2000029740</a>	Efficacy of therapeutic effects of hydroxycholoroquine in novel coronavirus pneumonia (COVID-19) patients(randomized open-label control clinical trial)	China	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Oxygen parameters	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49869">ChiCTR2000030054</a>	An open randomized controlled trial for Chloroquine phosphate and Hydroxychloroquine sulfate in the treatment of mild and common novel coronavirus pneumonia (COVID-19)	China	Y	Y	Drug Repurposing	Chloroquine, Hydroxychloroquine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49544">ChiCTR2000030039</a>	Clinical study for infusing convalescent plasma to treat patients with new coronavirus pneumonia (COVID-19)	China	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49812">ChiCTR2000030020</a>	The clinical application and basic research related to mesenchymal stem cells to treat novel coronavirus pneumonia (COVID-19)	China	N	N	Shelved drug or NME	ND:MSC	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49738">ChiCTR2000030002</a>	Clinical study for novel NLRP Inflammasome inhibitor (Tranilast) in the treatment of novel coronavirus (COVID-19)	China	Y	N	Drug Repurposing	Tranilast	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49720">ChiCTR2000029989</a>	A randomized controlled Trial for therapeutic efficacy of Recombinant Human Interferon alpha 1b Eye Drops in the treatment of elderly with novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Interferon alpha 1b	Efficacy - Oxygen parameters	Other	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49218">ChiCTR2000029988</a>	Clinical Study of Chloroquine Phosphate in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Chloroquine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50380">ChiCTR2000030442</a>	The therapeutic efficacy of combination of Tocilizumab, IVIG and CRRT in sever patients with novel coronavirus pneumonia (COVID-19)	China	N	N	Drug Repurposing, Cell/Blood based	Tocilizumab	Efficacy - Other efficacy	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50174">ChiCTR2000030424</a>	A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)	China	N	N	Shelved drug or NME	Azvudine	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50173">ChiCTR2000030398</a>	A randomized, double-blind, placebo-controlled trial for evaluation of  the efficacy and safety of bismuth potassium citrate capsules in the treatment of patients with novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Bismuth potassium citrate	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50136">ChiCTR2000030262</a>	Clinical study for combination of anti-viral drugs and type I interferon and inflammation inhibitor TFF2 in the treatment of novel coronavirus pneumonia (COVID-19)	China	Y	N	Shelved drug or NME	TFF2	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49691">ChiCTR2000030265</a>	Clinical research program of continuous renal replacement therapy with adsorption filter for the treatment of the novel coronavirus pneumonia (COVID-19)	China	Y	N	Cell/Blood based	ND:Continuous renal replacement therapy	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49963">ChiCTR2000030261</a>	A study for the key technology of mesenchymal stem cells exosomes atomization in the treatment of novel coronavirus pneumonia (COVID-19)	China	Y	N	Cell/Blood based	ND:MSC	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49883">ChiCTR2000030196</a>	A multicenter, single arm, open label trial for the efficacy and safety of CMAB806 in the treatment of cytokine release syndrome of novel coronavirus pneumonia (COVID-19)	China	N	N	Drug Repurposing	Tocilizumab	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49918">ChiCTR2000030259</a>	Evaluation Danorevir sodium tablets combined with ritonavir in the treatment of novel coronavirus infection (COVID-19): a randomized, open and controlled trial	China	Y	N	Drug Repurposing, Shelved drug or NME	Danoprevir, Ritonavir	Efficacy - Oxygen parameters	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49796">ChiCTR2000030013</a>	A study on the efficacy and safety of recombinant human interferon alpha 1b spray in preventing novel coronavirus (COVID-19) infection in highly exposed medical staffs.	China	Y	N	Drug Repurposing	Interferon alpha 1b	Safety	Exposed individuals (family members, HCP)	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49592">ChiCTR2000029975</a>	Single arm study for exploration of chloroquine phosphate aerosol inhalation in the treatment of novel coronavirus pneumonia (COVID-19)	China	N	N	Drug Repurposing	Chloroquine	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49400">ChiCTR2000029761</a>	Multicenter, randomized, open clinical study of Hydroxychloroquine Sulfate tablets in the treatment of common patients with novel coronavirus pneumonia (COVID-19)	China	Y	Y	Drug Repurposing	Hydroxychloroquine	Efficacy - Viral load	Mild/Moderate Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49404">ChiCTR2000029762</a>	A randomized, open-label, controlled trial for the efficacy and safety of hydroxychloroquine sulfate tablets in the treatment of patients with severe novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Viral load	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=48782">ChiCTR2000029387</a>	Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia	China	Y	Y	Drug Repurposing	Ribavirin, Interferon alpha, Lopinavir/ritonavir	Efficacy - Viral load	Mild/Moderate Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49536">ChiCTR2000029899</a>	Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Mild and Commen Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-label, Parallel, Controlled Trial	China	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=48777">ChiCTR2000029386</a>	A study on treatment strategies of novel coronavirus pnueumonia patients	China	Y	N	Drug Repurposing	Methylprednisolone	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49369">ChiCTR2000029760</a>	A randomized controlled study to evaluate the efficacy and safety of hydroxychloroquine for mild and moderate COVID-19 Infectious diseases	China	Y	N	Drug Repurposing	Hydroxychloroquine, Lopinavir/ritonavir	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49482">ChiCTR2000029898</a>	Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Severe Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-Label, Parallel, Controlled Trial	China	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49790">ChiCTR2000030535</a>	Multi-Center Clinical Study on the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19) by Ebastine	China	Y	N	Drug Repurposing	Ebastine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50507">ChiCTR2000030487</a>	A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)	China	N	N	Shelved drug or NME	Azvudine	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49753">ChiCTR2000030472</a>	An open and controlled clinical study to evaluate the efficacy and safety of Ganovo combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing, Shelved drug or NME	Danoprevir, Ritonavir	Efficacy - Oxygen parameters	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50421">ChiCTR2000030471</a>	Efficacy and safety of lipoic acid injection in reducing the risk of progression in common patients with novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Alpha Lipoic Acid	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50727">ChiCTR2000030627</a>	Study on the application of convalescent plasma therapy in severe COVID-19	China	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Viral load	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50258">ChiCTR2000030312</a>	A single-center, open-label and single arm trial to evaluate the efficacy and safety of anti-SARS-CoV-2 inactivated convalescent plasma in the treatment of novel coronavirus pneumonia (COVID-19) patient	China	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50263">ChiCTR2000030484</a>	HUMSCs and Exosomes Treating Patients with Lung Injury following Novel Coronavirus Pneumonia (COVID-19)	China	Y	N	Cell/Blood based	ND:MSC	Efficacy - Oxygen parameters	Other	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49088">ChiCTR2000029580</a>	Severe novel coronavirus pneumonia (COVID-19) patients treated with ruxolitinib in combination with mesenchymal stem cells: a prospective, single blind, randomized controlled clinical trial	China	Y	N	Drug Repurposing, Cell/Blood based	Ruxolitinib, ND:MSC	Safety	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49224">ChiCTR2000029638</a>	A Multicenter, Randomized, Controlled trial for Recombinant Super-Compound Interferon (rSIFN-co) in the Treatment of Novel Coronavirus Pneumonia (COVID-19)	China	Y	N	Shelved drug or NME	rSIFN-co	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49081">ChiCTR2000029757</a>	Convalescent plasma for the treatment of severe and critical novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial	China	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=48684">ChiCTR2000029308</a>	A randomized, controlled open-label trial to evaluate the efficacy and safety of lopinavir-ritonavir in hospitalized patients with 2019-nCoV infection	China	Y	N	Drug Repurposing	Lopinavir/ritonavir	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=51118">ChiCTR2000030892</a>	Efficacy and Safety of Pirfenidone in the Treatment of Severe Post-Novel Coronavirus Pneumonia (COVID-19)) Fibrosis:a prospective exploratory experimental medical study	China	Y	N	Drug Repurposing	Pirfenidone	Efficacy - Other efficacy	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=51081">ChiCTR2000030853</a>	Evaluation of the protective effect of dexmedetomidine on patients with severe new coronavirus pneumonia	China	N	N	Drug Repurposing	Dexmedetomidine	Efficacy - Other efficacy	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=51050">ChiCTR2000030835</a>	Clinical study on the efficacy of Mesenchymal stem cells (MSC) in the treatment of severe novel coronavirus pneumonia (COVID-19)	China	Y	N	Cell/Blood based	ND:MSC	Efficacy - Other efficacy	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=51072">ChiCTR2000030841</a>	Treatment of Acute Severe COVID-19 With Immunoglobulin From Cured COVID-19 Patients	China	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50973">ChiCTR2000030779</a>	A randomized, open-label, controlled trial for the efficacy and safety of  Ulinastatin Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19)	China	Y	N	Shelved drug or NME	Ulinastatin	Efficacy - Oxygen parameters	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50843">ChiCTR2000030718</a>	Clinical Study of Chloroquine Phosphate in the Treatment of 2019-nCoV Infection	China	Y	N	Drug Repurposing	Chloroquine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50795">ChiCTR2000030701</a>	A randomized, parallel controlled open-label trial to evaluate the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in adult hospitalized patients with novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Enoxaparin	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50251">ChiCTR2000030703</a>	A randomized, blinded, controlled, multicenter clinical trial to evaluate the efficacy and safety of Ixekizumab combined with conventional antiviral drugs in patients with novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Ixekizumab	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50786">ChiCTR2000030700</a>	An evaluative clinical study: efficacy and safety of of Prolongin (Enoxaparin Sodium Injection) in treatment of hospitalized adult patients with common novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Enoxaparin	Efficacy - Viral load	Mild/Moderate Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50693">ChiCTR2000030580</a>	Tozumab combined with adamumab(Qletli) in the treatment of severe and critically ill patients with novel coronavirus pneumonia (COVID-19):A prospective, single-center, randomized, parallel controlled trial	China	Y	N	Drug Repurposing	Adalimumab, Tocilizumab	Efficacy - Other efficacy	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49779">ChiCTR2000030329</a>	Clinical trial for umbilical cord blood CIK and NK cells in the treatment of mild and general patients infected with novel coronavirus pneumonia (COVID-19)	China	Y	N	Cell/Blood based	ND:Umbilical cord NK/CIK cells	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50537">ChiCTR2000030702</a>	Convalescent plasma for the treatment of common COVID-19: a prospective randomized controlled trial	China	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49915">ChiCTR2000030082</a>	Randomized controlled trial for the efficacy of dihydroartemisinine piperaquine in the treatment of mild/common novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Dihydroartemisinin/piperaquine	Efficacy - Viral load	Mild/Moderate Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49712">ChiCTR2000029984</a>	Study on the effect of human placenta biological preparation on the defense of immune function against novel coronavirus pneumonia (COVID-19)	China	Y	N	Cell/Blood based	ND:Human placenta extract	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50057">ChiCTR2000030187</a>	Efficacy and safety of Lopinavir and Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Lopinavir/ritonavir	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49806">ChiCTR2000030031</a>	A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in mild/common patients with novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Chloroquine	Efficacy - Viral load	Mild/Moderate Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49569">ChiCTR2000029895</a>	Single arm study for the efficacy and safety of GD31 in patients with novel coronavirus pneumonia (COVID-19)	China	N	N	Shelved drug or NME	GD31	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49384">ChiCTR2000029817</a>	Clinical Study of Cord Blood NK Cells Combined with Cord Blood Mesenchymal Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19)	China	Y	N	Cell/Blood based	ND:MSC, ND:NK cells	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49495">ChiCTR2000029837</a>	A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in mild/common patients with novel coronavirus pneumon (COVID-19)ia	China	Y	N	Drug Repurposing	Chloroquine	Efficacy - Viral load	Mild/Moderate Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49374">ChiCTR2000029812</a>	Clinical Study for Umbilical Cord Blood Mononuclear Cells in the Treatment of Acute Novel Coronavirus Pneumonia (NCP)	China	Y	N	Cell/Blood based	ND:Cord blood MNC	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49481">ChiCTR2000029826</a>	A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in serious/critically ill patients with novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Chloroquine	Efficacy - Mortality	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49956">ChiCTR2000030509</a>	Clinical Study of NK Cells in the Treatment of Novel Coronavirus Pneumonia (COVID-19)	China	Y	N	Cell/Blood based	ND:NK cells	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50279">ChiCTR2000030417</a>	Efficacy and safety of chloroquine phosphate inhalation combined with standard therapy in the treatment of novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Chloroquine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50290">ChiCTR2000030381</a>	A randomized, open-label, controlled and single-center trial to evaluate the efficacy and safety of anti-SARS-CoV-2 inactivated convalescent plasma in the treatment of novel coronavirus pneumonia (COVID-19) patient	China	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50002">ChiCTR2000030135</a>	A randomized controlled trial for high-dose Vitamin C in the treatment of severe and critical novel coronavirus pneumonia (COVID-19) patients	China	Y	N	Drug Repurposing	Ascorbic acid	Efficacy - Mortality	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=51416">ChiCTR2000031138</a>	Prospective exploratory clinical research on the efficacy and safety of pirfenidone capsules in the treatment of severe novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Pirfenidone	Efficacy - Other efficacy	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=51059">ChiCTR2000030939</a>	Preliminary evaluation of the safety and efficacy of oral LL-37 antiviral peptide (CAS001) in the treatment of novel coronavirus pneumonia	China	N	N	Shelved drug or NME	CSA0001	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=51141">ChiCTR2000030922</a>	Prospective, open-label, controlled, multicenter cohort study of long-acting interferon plus ribavirin in patients with COVID-19 infection	China	Y	N	Drug Repurposing	Interferon alpha 2a	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=51154">ChiCTR2000030906</a>	A single-center, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) in healthy adults aged between 18 and 60 years	China	Y	N	Vaccine	Adenoviral vaccine	Safety	General population	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=51404">ChiCTR2000031139</a>	Safety and Effectiveness of Human embryonic stem cell-derived M cells (CAStem) for Pulmonary Fibrosis Correlated with novel coronavirus pneumonia(COVID-19)	China	N	N	Cell/Blood based	ND:MSC	Efficacy - Oxygen parameters	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50696">ChiCTR2000030929</a>	A randomized, double-blind, parallel-controlled trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia (COVID-19)	China	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50137">ChiCTR2000030254</a>	the Efficacy and Safety of Favipiravir for novel coronavirus   infected pneumonia: A multicenter, randomized, open, positive, parallel-controlled clinical study	China	Y	N	Drug Repurposing	Favipiravir	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49968">ChiCTR2000030224</a>	Clinical study of mesenchymal stem cells in treating severe novel coronavirus pneumonia (COVID-19)	China	Y	N	Cell/Blood based	ND:MSC	Efficacy - Oxygen parameters	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=51329">ChiCTR2000030987</a>	Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Chloroquine, Favipiravir	Efficacy - Oxygen parameters	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=48809">ChiCTR2000029496</a>	A randomized, open label, parallel controlled trial for evaluating the efficacy of recombinant cytokine gene-derived protein injection on clearing novel coronavirus in patients with novel coronavirus pneumonia (COVID-19)	China	Y	N	Shelved drug or NME	Novaferon	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50199">ChiCTR2000030944</a>	An open, multi-center, control, exploratory clinical study of human NK cells and UC-MSCs transplantation for severe novel coronavirus pneumonia	China	Y	N	Cell/Blood based	ND:NK cells, ND:MSC	Efficacy - Other efficacy	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50660">ChiCTR2000030539</a>	Study for the effect of 3% hydrogen peroxide gargle on the Intraoral novel coronavirus of the patients with novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Hydrogen peroxide	Efficacy - Viral load	Mild/Moderate Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49524">ChiCTR2000029868</a>	Hydroxychloroquine treating novel coronavirus pneumonia (COVID-19): a randomized controlled, open label, multicenter trial	China	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49420">ChiCTR2000031204</a>	A multicenter, single-blind, randomized controlled clinical trial for chloroquine phosphate in the treatment of 2019 novel coronavirus-infected pneumonia	China	Y	N	Drug Repurposing	Chloroquine	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=51112">ChiCTR2000031196</a>	Clinical efficacy of novel coronavirus infection treated by combination of interferon regimen and Ritonavir Tablets	China	Y	N	Drug Repurposing	Lopinavir/ritonavir, Interferon	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49840">ChiCTR2000030028</a>	Clinical comparative study of PD-1 mAb in the treatment of severe and critical patients with novel coronavirus disease (COVID-19)	China	Y	N	Drug Repurposing	Anti-PD1 mab (unspecified)	Efficacy - Other efficacy	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=51904">ChiCTR2000031494</a>	Clinical study for stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19)	China	Y	N	Cell/Blood based	ND:MSC	Efficacy - Other efficacy	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50254">ChiCTR2000031501</a>	The efficacy  of convalescent plasma in patients with critical novel coronavirus pneumonia (COVID-19): a pragmatic, prospective cohort study	China	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Mortality	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50474">ChiCTR2000031630</a>	Clinical study for Celebrex in the treatment of novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Celecoxib	Other	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=51693">ChiCTR2000031454</a>	Clinical study for prevention and treatment of digestive tract lesions caused by novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Rabeprazole	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=49254">ChiCTR2000031430</a>	Evaluation of  the safety and efficacy for human umbilical cord mesenchymal stem cells in COVID-19 induced pulmonary fibrosis	China	Y	N	Cell/Blood based	ND:MSC	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://anzctr.org.au/ACTRN12620000417987.aspx">ACTRN12620000417987</a>	Multi-Site, Randomized, Open-Label, Parallel-Group, Placebo-Controlled Study to Assess the Chemoprophylactic Efficacy of Chloroquine Against SARS-CoV-2/COVID-19 in Healthcare Workers at High-Risk of Exposure	Australia	Y	N	Drug Repurposing	Chloroquine	Efficacy - Other efficacy	Exposed individuals (family members, HCP)	
<a href="https://anzctr.org.au/ACTRN12620000457943.aspx">ACTRN12620000457943</a>	A Randomised, Double Blind, Placebo-Controlled Trial of the Efficacy of Hydroxychloroquine for the Community-Based Treatment of Adults With Diagnosed COVID-19 	New Zealand	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://anzctr.org.au/ACTRN12620000454976.aspx">ACTRN12620000454976</a>	High-dose intravenous zinc (HDIVZn) as adjunctive therapy in COVID-19 positive critically ill patients: A pilot randomized controlled trial	Australia	Y	N	Drug Repurposing	Zinc chloride	Efficacy - Oxygen parameters	Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=52006">ChiCTR2000031781</a>	A randomized, double-blinded, placebo-controlled phase II clinical trial for Recombinant Novel Coronavirus (2019-nCOV) Vaccine (Adenovirus Vector) in healthy adults aged above 18 years	China	Y	N	Vaccine	Adenoviral vaccine	Efficacy - Other efficacy	General population	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50241">ChiCTR2000030328</a>	Clinical application of inhaled acetylcysteine solution in the treatment of novel coronavirus pneumonia (COVID-19)	China	Y	N	Drug Repurposing	N-acetylcysteine	Efficacy - Oxygen parameters	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50613">ChiCTR2000031735</a>	Clinical study for natural killer (NK) cells from umbilical cord blood in the treatment of viral pneumonia include novel coronavirus pneumonia (COVID-19)	China	Y	N	Cell/Blood based	ND:NK cells	Safety	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50928">ChiCTR2000030750</a>	A clinical study for effectiveness and safety evaluation for recombinant chimeric COVID-19 epitope DC vaccine in the treatment of novel coronavirus pneumonia	China	Y	N	Vaccine	Chimeric COVID-19 DC vaccine	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://anzctr.org.au/ACTRN12620000445976.aspx">ACTRN12620000445976</a>	Australasian COVID-19 Trial (ASCOT). A multi-centre randomised clinical trial to assess clinical, virological and immunological outcomes in patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care	Australia	Y	N	Drug Repurposing	Hydroxychloroquine, Lopinavir/ritonavir	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="http://www.chictr.org.cn/showproj.aspx?proj=50022">ChiCTR2000030300</a>	Umbilical cord mesenchymal stem cells for the treatment of patients at high risk of novel coronavirus pneumonia  (COVID-19): a single-center, prospective, open clinical study	China	N	N	Cell/Blood based	ND:MSC	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://trialregister.nl/trial/8490">NL8490</a>	An open label randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19	Netherlands	Y	Y	Drug Repurposing	Chloroquine, Hydroxychloroquine	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46576">IRCT20160625028622N1</a>	The effect of  NOSCOVID on pulmonary & other clinical manifestations of COVID-19 patients	Iran	Y	N	Drug Repurposing	Noscapine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://jrct.niph.go.jp/latest-detail/jRCTs031190226">JPRN-jRCTs031190226</a>	A prospective multi-center open trial to evaluate the safety and efficacy of favipiravir in patients infected with COVID-19.	Japan	N	N	Drug Repurposing	Favipiravir	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://jrct.niph.go.jp/latest-detail/jRCTs031190227">JPRN-jRCTs031190227</a>	A prospective multi-center open trial to evaluate the safety and efficacy of triple combination therapy of  lopinavir , ritonavir and hydroxychloroquine sulfate in patients infected with COVID-19.	Japan	N	N	Drug Repurposing	Hydroxychloroquine, Lopinavir/ritonavir	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://jrct.niph.go.jp/latest-detail/jRCTs041190120">JPRN-jRCTs041190120</a>	Multicenter, open-label, randomized trial of favipiravir in asymptomatic and minimally symptomatic patients infected with SARS-CoV2 to evaluate viral load reduction	Japan	Y	N	Drug Repurposing	Favipiravir	Efficacy - Viral load	Mild/Moderate Cases	
<a href="http://isrctn.com/ISRCTN83971151">ISRCTN83971151</a>	An international randomized trial of additional treatments for COVID-19 in hospitalized patients who are all receiving the local standard of care	Switzerland	Y	Y	Drug Repurposing	Remdesivir, Chloroquine, Hydroxychloroquine, Lopinavir/ritonavir, Interferon beta	Efficacy - WHO scale	General population, Severe Cases	
<a href="http://en.irct.ir/trial/46567">IRCT20100228003449N29</a>	Evaluating efficacy and safety of sofosbuvir/ ledipasvir in  treatment of COVID-19	Iran	Y	N	Drug Repurposing	Ledipasvir/sofosbuvir	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="http://en.irct.ir/trial/46536">IRCT20100228003449N30</a>	Evaluating efficacy and safety of hydroxychloroquine + lopinavir or atazanavir/ritonavir combination  in patients with COVID-19	Iran	N	N	Drug Repurposing	Hydroxychloroquine, Atazanavir/ritonavir, Lopinavir/ritonavir	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="http://en.irct.ir/trial/46538">IRCT20100228003449N28</a>	Evaluating efficacy and safety of interferone   -1a in the treatment COVID-19 infection	Iran	Y	N	Drug Repurposing	Interferon beta-1a	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="http://en.irct.ir/trial/46545">IRCT20100228003449N27</a>	Evaluating efficacy and safety of interferone   -1b (IFN   -1b) in the treatment of COVID-19	Iran	Y	N	Drug Repurposing	Interferon beta-1b	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="http://en.irct.ir/trial/46463">IRCT20200128046294N2</a>	A prospective randomized controlled trial comparing Sovodak (Sofosbuvir plus Daclatasvir) in participants with moderate to severe Coronavirus disease (COVID-19) compared to standard of care treatment	Iran	Y	N	Drug Repurposing	Daclatasvir/sofosbuvir	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46561">IRCT20151227025726N12</a>	Evaluting the therapeutic and adverse effects of Interferon beta 1-a subcutaneous administration in patients with novel Coronavirus (COVID-19)	Iran	N	N	Drug Repurposing	Interferon beta-1a	Efficacy - Other efficacy	Severe Cases	
<a href="http://en.irct.ir/trial/46693">IRCT20160310026998N10</a>	Study of the metformin effect on the survival and recovery rate of COVID-19 patients	Iran	Y	N	Drug Repurposing	Metformin	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46624">IRCT20200321046828N1</a>	The effect of genetical nanocomposit drug with cell imunity level on human coronavirus (COVID-19)	Iran	Y	Y	Shelved drug or NME	NOS	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46759">IRCT20200325046860N1</a>	Evaluation of Convalescent Plasma as a Potential Therapy for COVID-19 infected patients	Iran	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Oxygen parameters	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46713">IRCT20200324046850N2</a>	Comparison of the effect of Sofosbuvir + Daclatasvir (Sovodac) and Ribavirin in Covid-19 Patients with Severe Symptoms	Iran	N	N	Drug Repurposing	Daclatasvir/sofosbuvir, Ribavirin	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="http://en.irct.ir/trial/46660">IRCT20171122037571N2</a>	A single-arm multicenter clinical trial to evaluate the safety and efficacy of Remdesivir in COVID-19 patients with progressive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)	Iran	N	N	Shelved drug or NME	Remdesivir	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46681">IRCT20151227025726N13</a>	Evaluation the Efficacy and Safety of Tocilizumab in Patients with Novel Coronavirus (COVID-19)	Iran	N	N	Drug Repurposing	Tocilizumab, Hydroxychloroquine, Oseltamivir, Lopinavir/Ritonavir, Interferon beta-1a	Efficacy - Other efficacy	Severe Cases	
<a href="http://en.irct.ir/trial/46732">IRCT20200324046850N1</a>	Comparison of vitamin D3 and N-acetylcysteine prescription in COVID19 patients   and their effect on recovery process	Iran	Y	Y	Drug Repurposing	Vitamin D, N-acetylcysteine	Efficacy - Other efficacy	Severe Cases	
<a href="http://en.irct.ir/trial/46741">IRCT20190804044429N1</a>	Efficacy and safety evaluation of therapeutic regimen of lopinavir/ritonavir and interferon beta 1b in patients with COVID-19	Iran	Y	N	Drug Repurposing	Interferon beta-1b, Hydroxychloroquine, Lopinavir/ritonavir	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46751">IRCT20200324046850N5</a>	Study of the effect of Vitamin C on duration of hospital stay in patients with Covid-19	Iran	Y	N	Drug Repurposing	Ascorbic acid	Efficacy - Other efficacy	Severe Cases	
<a href="http://en.irct.ir/trial/46776">IRCT20200204046369N1</a>	Evaluation of Methylprednisolone Administration as a Therapeutic Option in the 2019 Novel Coronavirus (COVID-19): A Non-Randomized Controlled Study	Iran	N	N	Drug Repurposing	Methylprednisolone	Efficacy - Oxygen parameters	Severe Cases	
<a href="http://en.irct.ir/trial/46804">IRCT20190917044805N2</a>	Effects of High-dose Vitamin C on Treatment, Clinical Symptoms and Laboratory Signs of Iranian COVID-19 Patients: A Double Blind Randomized Clinical Trial	Iran	Y	N	Drug Repurposing	Ascorbic acid	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46810">IRCT20120225009124N4</a>	Efficacy of different methods of administeration of combination regiemn including dexamethasone, IV-IG and Interferone beta for treatment of patients with severe COVID-19: a randomized controlled trial	Iran	Y	Y	Drug Repurposing	Dexamethasone, Interferon beta, ND:Immunoglobulin	Efficacy - Oxygen parameters	Severe Cases	
<a href="http://en.irct.ir/trial/46786">IRCT20200317046797N2</a>	Effect of Fingolimod for treatment of COVID-19-induced cytokine storm	Iran	Y	N	Drug Repurposing	Fingolimod	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="http://en.irct.ir/trial/46783">IRCT20200318046812N1</a>	Evaluation of safety and efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra on the need for intensive care unit treatment in patients with COVID-19; a randomized, multicenter, parallel groups, open label study	Iran	Y	N	Drug Repurposing	Favipiravir	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46811">IRCT20200325046859N1</a>	Evaluation of the efficacy of intravenous immunoglobulin (IVIg) in patients with severe  COVID-19 (Before intubation phase) who have not responded to treatment with the standard three-drug protocol (hydroxychloroquine / chloroquine + lupinavir / ritonavir + ribavirin)	Iran	N	N	Cell/Blood based	ND:Immunoglobulin	Efficacy - Other efficacy	Severe Cases	
<a href="http://en.irct.ir/trial/46789">IRCT20200325046860N2</a>	Mesenchymal stem cell utilization in reducing complications and enhancing pneumonia healing  in patients infected with 2019-nCoV (phase I clinical trial)	Iran	N	N	Cell/Blood based	ND:Stem cells	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46837">IRCT20150704023055N2</a>	To evaluate the effectiveness of hemoperfusion in patients with severe coronavirus disease 2019 (COVID-19)	Iran	N	N	Cell/Blood based	ND:Procedure	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="http://en.irct.ir/trial/46838">IRCT20200319046819N1</a>	Impact of vitamin B, A, D, E, C supplementation on improvement and mortality rate in patients with COVID-19 admitted in intensive care unit	Iran	Y	N	Drug Repurposing, Other	Ascorbic acid, ND:Vitamin supplementation	Efficacy - Other efficacy	Severe Cases	
<a href="http://en.irct.ir/trial/46849">IRCT20130917014693N10</a>	Evaluation the efficacy and safety of Hydroxychloroquine administration for COVID-19 post exposure prophylaxis	Iran	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Other efficacy	Exposed individuals (family members, HCP)	
<a href="http://en.irct.ir/trial/46875">IRCT20200401046909N1</a>	The efficacy of oral 25-hydroxyvitamin D3 on  COVID-19 treatment in adults: A Randomized, Controlled Double-Blind Clinical Trial.	Iran	Y	N	Drug Repurposing	Vitamin D	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46932">IRCT20130306012728N8</a>	Prospective post-exposure hydroxycloroquine prophylaxis for Covid 19 (PROSCLOROCOV 19)	Iran	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="http://en.irct.ir/trial/46790">IRCT20130812014333N145</a>	Comparative assessment of the efficacy and safety of add ontreatment with    Sofosbuvir plus Velpatasvir    to    standard of care therapeutic regimen    in patients with COVID-19	Iran	Y	N	Drug Repurposing	Sofosbuvir/velpatasvir	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46968">IRCT20200318046812N2</a>	Safety and efficacy of    Hydroxychloroquine + Azithromycin + Naproxen + Prednisolone    and    Hydroxychloroquine + Azithromycin + Naproxen    regimens in comparison with    Hydroxychloroquine + kaletra    on the need for intensive care unit treatment in patients with COVID-19; a randomized, multicenter, parallel groups, open label study	Iran	Y	N	Drug Repurposing	Prednisolone	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46942">IRCT20151227025726N14</a>	Evaluation the efficacy and safety of Favipiravir made by Shahid Beheshti University of Medical Sciences in comparison with Lopinavir-ritonavir in COVID-19 patients	Iran	Y	N	Drug Repurposing	Favipiravir	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46969">IRCT20200317046797N4</a>	Effect of Bromhexine Hydrochloride on clinical improvement and outcome of  COVID-19-induced pneumonia	Iran	Y	N	Drug Repurposing	Bromhexine	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="http://en.irct.ir/trial/47022">IRCT20150808023559N20</a>	Evaluation of safety and efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra in  hospitalized patients with COVID-19	Iran	Y	N	Drug Repurposing	Favipiravir	Efficacy - Mortality	Severe Cases	
<a href="http://en.irct.ir/trial/46814">IRCT20161204031229N3</a>	Study of the Efficacy of Teicoplanin on mortality rate of patients with  COVID-19 Infection: A randomized clinical trial	Iran	Y	N	Drug Repurposing	Teicoplanin	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46824">IRCT20180802040678N4</a>	Evaluation of the effects of Losartan in patients with corona virus disease 2019	Iran	Y	N	Drug Repurposing	Losartan	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46946">IRCT20200405046958N1</a>	Effect of Hydroxychloroquine on Novel Coronavirus Disease (COVID-19) prevention in cancer patients under treatment	Iran	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Other	
<a href="http://en.irct.ir/trial/47030">IRCT20200217046526N1</a>	Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection : A Phase 1 and 2 clinical trial	Iran	N	N	Cell/Blood based	ND:Stem cells	Safety	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/47010">IRCT20200401046909N2</a>	Investigating preventive effects of oral 25-hydroxyvitamin D3 on COVID-19 in adults: A  Randomized, Controlled Double-Blind Clinical Trial.	Iran	Y	N	Drug Repurposing	Vitamin D	Efficacy - Infection rate (prevention)	General population	
<a href="http://en.irct.ir/trial/46897">IRCT20180725040596N2</a>	Evaluation of the effect of Arbidol drug in the treatment of hospitalized patients with COVID-19	Iran	Y	N	Drug Repurposing	Umifenovir	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="http://en.irct.ir/trial/46974">IRCT20180520039738N2</a>	Comparison of the effectiveness of standard treatment with stand treatment plus Vitamin A in treatment in covid19 patients	Iran	Y	N	Drug Repurposing	Vitamin A	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/47014">IRCT20200317046797N3</a>	To evaluate the effectiveness of intravenous immunoglobulin (IVIG) for the treatment of COVID-19-induced cytokine storm	Iran	Y	N	Cell/Blood based	ND:Immunoglobulin	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="http://en.irct.ir/trial/46904">IRCT20200404046947N1</a>	Study of Methylprednisolone effects on treatment and clinical symptoms and laboratory signs of Iranian ?COVID-19 patients: a clinical trial study	Iran	Y	N	Drug Repurposing	Methylprednisolone	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="http://en.irct.ir/trial/46926">IRCT20200403046926N1</a>	The effect of adding SOVODAK (sofosbuvir+daclatasvir) to the treatment protocol of COVID-19 outpatients: A Clinical Trial Study	Iran	Y	N	Drug Repurposing	Sofosbuvir/daclatasvir	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46931">IRCT20151228025732N53</a>	Evaluation of the therapeutic effects of Convalescent Plasma (CP) of recovered people from Covid-19 in improving clinical and laboratory symptoms of hospitalized patients	Iran	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Oxygen parameters	Severe Cases	
<a href="http://en.irct.ir/trial/47073">IRCT20200217046526N2</a>	Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection: A Phase 2-3 Clinical Trial	Iran	Y	N	Cell/Blood based	ND:Stem cells	Safety	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46973">IRCT20200404046948N1</a>	Randomized, parallel-controlled and multi-center clinical study evaluating the efficacy and safety of convalescent  plasma, in the treatment of patients with severe SARS-CoV-2 infection (COVID-19)	Iran	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - WHO scale	Severe Cases	
<a href="http://en.irct.ir/trial/46977">IRCT20081019001369N4</a>	Clinical trial of minocycline against COVID-19	Iran	Y	N	Drug Repurposing	Minocycline	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/47078">IRCT20200411047025N1</a>	Evaluation of effectiveness? of Intravenous vitamin c in Patients with COVID-19 Referred to Imam ?Khomeini Hospital: a clinical trial ?	Iran	Y	N	Drug Repurposing	Ascorbic acid	Efficacy - Oxygen parameters	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/47087">IRCT20080901001165N46</a>	Investigating the efficacy and safety of Umifenovir in controlling the symptoms of patients with COVID-19	Iran	Y	N	Drug Repurposing	Umifenovir	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/47006">IRCT20200408046992N1</a>	Evaluation of the Effect  of  Trifluoperazin in Treatment of   Patients with Confirmed 2019 Novel Coronavirus(COVID- 19): An Open-Label Randomized Clinical Trial	Iran	Y	N	Drug Repurposing	Trifluoperazin	Efficacy - WHO scale	Severe Cases	
<a href="http://en.irct.ir/trial/47244">IRCT20200415047092N1</a>	Safety and Effectiveness of azithromycin in Patients with COVID-19 Referred to zeiaeian Hospital : A clinical trial study	Iran	Y	N	Drug Repurposing	Azithromycin	Efficacy - Other efficacy	Severe Cases	
<a href="http://en.irct.ir/trial/47021">IRCT20200406046968N1</a>	The  effect of IL-6 inhibitor (Tocilizumab) on the prognosis of covid-19 patients with acute respiratory failure	Iran	N	N	Drug Repurposing	Tocilizumab	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/47058">IRCT20200409047007N1</a>	The effect of plasma administration of COVID-19 survivors in patients with acute respiratory distress syndrome due to COVID-19	Iran	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Mortality	Mild/Moderate Cases, Other	
<a href="http://en.irct.ir/trial/47090">IRCT20190122042450N4</a>	Prevention of COVID-19 disease after contact with an infected patient with coronavirus after taking hydroxychloroquine in the community	Iran	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Other efficacy	Exposed individuals (family members, HCP)	
<a href="https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205238">JPRN-JapicCTI-205238</a>	Multicenter, Adaptive, Randomized, Placebo-Controlled, Comparative Study to Evaluate the Efficacy and Safety of Favipiravir in Patients with COVID-19 Non-Severe Pneumonia	Japan	Y	N	Drug Repurposing	Favipiravir	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="http://en.irct.ir/trial/47099">IRCT20200411047030N1</a>	Evaluation of adding melatonin to routine treatment on outcomes and quality of sleep in COVID-19 patients	Iran	N	N	Drug Repurposing	Melatonin	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/47212">IRCT20200413047056N1</a>	Comparison between the efficacy of intravenous immunoglobulin and convalescent plasma in improving the condition of patients with COVID-19: A randomized clinical trial	Iran	Y	N	Cell/Blood based	ND:Immunoglobulin, ND:Convalescent plasma	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://jrct.niph.go.jp/latest-detail/jRCTs031190269">JPRN-jRCTs031190269</a>	A multicenter, open-label, randomized controlled trial to evaluate the efficacy and safety of inhaled ciclesonide for asymptomatic and mild patients with COVID-19 - RACCO trial	Japan	Y	N	Drug Repurposing	Ciclesonide	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="http://www.ensaiosclinicos.gov.br/rg/RBR-3cbs3w/">RBR-3cbs3w</a>	Randomized, pragmatic, open study evaluating Hydroxychloroquine for prevention of Hospitalization and Respiratory Complications in outpatients with confirmed or presumptive diagnosis of Infection by (COVID-19)	Brazil	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10928">PACTR202004801273802</a>	A Single-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of Chloroquine Phosphate and Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients in Lagos State	Nigeria	Y	N	Drug Repurposing	Chloroquine, Hydroxychloroquine	Efficacy - WHO scale	Severe Cases	
<a href="http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5995">TCTR20200404004</a>	Comparative effectiveness of chloroquine and vitamin C prophylaxis in household contacts of confirmed COVID-19 patients	Thailand	Y	N	Drug Repurposing	Chloroquine, Ascorbic acid	Efficacy - Viral load	Mild/Moderate Cases	
<a href="http://rpcec.sld.cu/en/trials/RPCEC00000306-En">RPCEC00000306</a>	Randomized control clinical trial of CIGB 2020 in contacts and SARS-CoV-2 infection suspects (COVID-19)	Cuba	Y	N	Shelved drug or NME	CIGB 2020 vaccine	Efficacy - Other efficacy	Exposed individuals (family members, HCP)	
<a href="http://www.ensaiosclinicos.gov.br/rg/RBR-8969zg/">RBR-8969zg</a>	Clinical Trial using N-acetylcysteine for treatment of 2019-nCoV Pneumonia	Brazil	Y	N	Drug Repurposing	N-acetylcysteine	Efficacy - Mortality	Severe Cases	
<a href="https://anzctr.org.au/ACTRN12620000480987.aspx">ACTRN12620000480987</a>	Stress-reduction Using Probiotics to Promote Ongoing Resilience Throughout COVID-19 for Healthcare Workers: A randomised placebo-controlled trial	New Zealand	Y	N	Drug Repurposing	Lactobacillus rhamnosus HN001	Other	Exposed individuals (family members, HCP)	
<a href="https://anzctr.org.au/ACTRN12620000473965.aspx">ACTRN12620000473965</a>	Reducing acute severe respiratory events in health care workers during the Covid-19 pandemic with OM85	Australia	Y	N	Drug Repurposing	OM-85	Efficacy - Other efficacy	Exposed individuals (family members, HCP)	
<a href="https://anzctr.org.au/ACTRN12620000478910.aspx">ACTRN12620000478910</a>	Cord Blood Therapy to prevent progression of COVID-19 related pneumonia	Australia	Y	N	Cell/Blood based	ND:Stem cells	Safety	Mild/Moderate Cases	
<a href="http://isrctn.com/ISRCTN14326006">ISRCTN14326006</a>	Protecting frontline health care workers from COVID-19 with hydroxychloroquine pre-exposure prophylaxis: a randomized, placebo-controlled multi-site trial in Toronto, Canada	Canada	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="http://www.drks.de/DRKS00021214">DRKS00021214</a>	Improvement of the nutritional status regarding nicotinamide (vitamin B3) and the course of COVID-19 disease - COVit	Germany	Y	N	Drug Repurposing	Nicotinamide	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="http://en.irct.ir/trial/46564">IRCT20170117032004N3</a>	evaluation the effect of vitamin A on respiratory signs and hospitalization in patients with COVID-19	Iran	Y	N	Drug Repurposing	Vitamin A	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="http://en.irct.ir/trial/46424">IRCT20200310046736N1</a>	Comparison of The Therapeutic Effect of Convalescent Plasma and Plasma-derived Immunoglobulin-enriched solution on COVID-19 Patients: A Clinical Trial Study	Iran	Y	Y	Cell/Blood based	ND:Convalescent plasma	Efficacy - Other efficacy	Severe Cases	
<a href="http://en.irct.ir/trial/46531">IRCT20151113025025N3</a>	Clinical Trial of renin-angiotensin-aldosterone system inhibitors with halting their administration and the effect on clinical outcomes of patients with corona virus disease-2019 (COVID-19) referring to Sina Hospital in 2020	Iran	N	N	Drug Repurposing, Other		Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46551">IRCT20200312046749N1</a>	Evaluation the efficacy of Tumor Necrosis Factor alpha inhibitor in COVID-19 outcomes: a prospective clinical trial study.	Iran	N	N	Drug Repurposing	Etanercept biosimilar	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42713">CTRI/2020/04/024479</a>	Open labelled Randomised controlled trial to study the effect of Chloroquine in addition to standard therapy in COVID-19 patients	India	Y	N	Drug Repurposing	Chloroquine	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46668">IRCT20140911019125N6</a>	Study the effect of intravenous injection of dental pulp mesenchymal stem cells in treatment of patients with COVID-19 pneumonia	Iran	N	N	Cell/Blood based	ND:Stem cells	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42638">CTRI/2020/03/024402</a>	Hydroxy Chloroquine, in open labelled, Randomised intervention for prevention of new infection and adverse outcomes following COVID-19 infection- A Tertiary Hospital based study - CORONA study	India	N	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="http://en.irct.ir/trial/46573">IRCT20200317046797N1</a>	Effect of Camostate mesylate on clinical improvement and outcome of  Coronavirus (COVID-19)-induced pneumonia	Iran	Y	N	Drug Repurposing	Camostat	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46603">IRCT20120826010664N6</a>	Effect of hydroxychloroquine on prevention of covid-19 virus infection among treatment staff in Arash hospital-A double-blind clinical trial	Iran	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="http://en.irct.ir/trial/46550">IRCT20150303021315N17</a>	Evaluation of the safety and efficacy of Tocilizumab (AryoGen ?pharmed Co. Iran) in patients with COVID-19?	Iran	N	N	Drug Repurposing	Tocilizumab	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46623">IRCT20140528017891N8</a>	Evaluation of the efficacy and safety of cord-derived mesenchymal stem cell transplantation in the treatment of COVID-19	Iran	N	N	Cell/Blood based	ND:Stem cells	Efficacy - Mortality	Severe Cases	
<a href="http://en.irct.ir/trial/46629">IRCT20190727044343N1</a>	The effect of febuxostat against lung injury induced by COVID-19 virus in infected patients: A clinical trial study	Iran	Y	N	Drug Repurposing	Febuxostat	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="http://en.irct.ir/trial/46718">IRCT20200324046850N3</a>	The effect of naproxen on the healing process of patients with COVID-19	Iran	Y	N	Drug Repurposing	Naproxen	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46533">IRCT20200314046764N1</a>	The evaluation of pirfenidone effects on prevention and treatment of pulmonary fibrosis and acute respiratory distress syndrome caused by COVID-19	Iran	Y	N	Drug Repurposing	Pirfenidone	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46665">IRCT20150914024017N1</a>	the efficacy of Interferon beta 1 a (ReciGen)  in treatment of patients with Covid-19 in Sina Hospital Emergency Department	Iran	Y	N	Drug Repurposing	Interferon beta-1a	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="http://en.irct.ir/trial/46639">IRCT20190727044343N2</a>	Atorvastatin effect in Clinical and Laboratory findings of patiens with COVID-19 admitted RAZI referral hospital in Mazandaran State: A Randomized Clinical Trial	Iran	Y	N	Drug Repurposing	Atorvastatin	Other	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04343677">NCT04343677</a>	Military COVID-19 Hydroxychloroquine Pre-exposure and Post-exposure Prophylaxis Study	United States	Y	Y	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001194-69/ES">2020-001194-69</a>	Pilot study to evaluate the efficacy and safety of mefloquine as prophylaxis in people exposed to the disease caused by the SARS-CoV-2 coronavirus (COVID-19)	Spain	Y	N	Drug Repurposing	Mefloquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001459-42/DK">2020-001459-42</a>	Ruxolitinib Treatment in Patients with Severe COVID-19 Infection. A Danish Safety and Efficacy Study.	Denmark	N	N	Drug Repurposing	Ruxolitinib	Efficacy - Mortality	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001421-31/ES">2020-001421-31</a>	Clinical trial randomized, unblinded and controled for evaluation of efficacy and safety of hydroxychloroquine chemoprophylaxis against SARS-CoV-2 (COVID-19) infection in healthcare professionals.	Spain	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001527-14/NL">2020-001527-14</a>	COVID-19: addition of azithromycin to chloroquine treatment	Netherlands	Y	N	Drug Repurposing	Azithromycin	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001209-22/GB">2020-001209-22</a>	Platform Randomised trial of INterventions against COVID-19 In older peoPLE	United Kingdom	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Other efficacy	General population	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001440-26/ES">2020-001440-26</a>	Pilot, double-blind clinical trial to evaluate the efficacy and safety of pre-exposure use of hydroxychloroquine versus placebo in the prevention of SARS-CoV-2 (COVID-19) infection in healthcare personnel.	Spain	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001375-32/NL">2020-001375-32</a>	Pre-emptive tocilizumab in hypoxic COVID-19 patients, a prospective randomized trial	Netherlands	Y	N	Drug Repurposing	Tocilizumab	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001327-13/AT">2020-001327-13</a>	A SINGLE-BLINDED RANDOMIZED, PLACEBO-CONTROLLED PHASE II TRIAL OF PROPHYLACTIC TREATMENT WITH ORAL AZITHROMYCIN VERSUS PLACEBO IN CANCER PATIENTS UNDERGOING ANTINEOPLASTIC TREATMENT DURING THE COVID-19 PANDEMIC	Austria	N	N	Drug Repurposing	Azithromycin	Efficacy - Infection rate (prevention)	Other	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001448-24/GB">2020-001448-24</a>	Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19	United Kingdom	Y	Y	Drug Repurposing	Hydroxychloroquine, Ritonavir/lopinavir	Efficacy - Other efficacy	General population	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001587-29/ES">2020-001587-29</a>	Hydroxychloroquine efficacy in preventing SARS-CoV-2 infection and CoVid-19 disease severity during pregnancy	Spain	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Viral load	Exposed individuals (family members, HCP), Mild/Moderate Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001765-37/ES">2020-001765-37</a>	Pragmatic clinical trial to evaluate the efficacy of hydroxychloroquine in the treatment of COVID-19 infection in two cohorts: patients with oncohaematological disease and SARS-CoV-2 positive without radiological alteration and sars-cov-2 positive professionals without radiological alteration	Spain	N	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Clinical improvement (except WHO scale)	Other	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001536-98/ES">2020-001536-98</a>	Prophylaxis of COVID-19 infection with hydroxychloroquine in healthcare&#13; personnel with high risk of infection.	Spain	N	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001386-37/IT">2020-001386-37</a>	Uno studio randomizzato multicentrico in aperto per valutare l&rsquo;efficacia della somministrazione precoce del Tocilizumab (TCZ) in pazienti affetti da polmonite da COVID-19.	Italy	Y	N	Drug Repurposing	Tocilizumab	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001492-33/FR">2020-001492-33</a>	Interest in the administration of Dornase alpha aerosol in ARDS secondary to respiratory infection by the coronavirus SRASCoV-2 / COVID-19	France	Y	N	Drug Repurposing	Dornase aplha	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001408-41/DE">2020-001408-41</a>	A prospective, randomized, double blinded placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia	Germany	Y	N	Drug Repurposing	Tocilizumab	Efficacy - Other efficacy	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001445-39/ES">2020-001445-39</a>	PRAGMATIC, CONTROLLED, OPEN, SINGLE CENTER, RANDOMIZED, PHASE II CLINICAL TRIAL TO EVALUATE METHYLPREDNISOLONE PULSES AND TACROLIMUS IN HOSPITALIZED PATIENTS WITH SEVERE PNEUMONIA SECONDARY TO COVID-19 (TACROVID)	Spain	Y	N	Drug Repurposing	Methylprednisolone, Tacrolimus	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001367-88/DK">2020-001367-88</a>	Efficacy and safety of novel treatment options for adults with COVID-19 pneumonia. A double-blinded, randomized, multi-stage, 6-armed placebo-controlled trial in the framework of an adaptive trial platform	Denmark	Y	Y	Drug Repurposing, Cell/Blood based	Hydroxychloroquine, Baricitinib, Sarilumab, ND:Convalescent plasma	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001682-36/ES">2020-001682-36</a>	Double-blind, placebo-controlled phase I/II clinical trial to evaluate the safety and efficacy of allogeneic mesenchymal stem cells (MSV&reg;-allo) in acute respiratory failure in patients with COVID-19 pneumonia.&#13;	Spain	Y	N	Cell/Blood based	ND:Stem cells	Efficacy - Other efficacy	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001469-35/PL">2020-001469-35</a>	A multicenter, open, randomized, non-commercial study to evaluate the efficacy and safety of chloroquine phosphate in the outpatient treatment of COVID-19 in combination with telemedicine care for patients with SARS-CoV-2 infection with the risk of developing complications to reduce the risk of COVID-19-related hospitalization and death.	Poland	Y	N	Drug Repurposing	Chloroquine	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001243-15/BE">2020-001243-15</a>	Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.	Belgium	Y	N	Drug Repurposing	Itraconazole	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001250-21/FR">2020-001250-21</a>	COVID-19 - Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease upon Hydroxychloroquine and Azithromycin Therapy in French Cancer patients	France	N	N	Drug Repurposing	Hydroxychloroquine, Azithromycin	Efficacy - Clinical improvement (except WHO scale)	Other	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001606-33/ES">2020-001606-33</a>	Randomized clinical trial to evaluate the efficacy of hydroxychloroquine associated or not with azithromycin as a treatment for COVID-19 infection.	Spain	Y	N	Drug Repurposing	Hydroxychloroquine, Azithromycin	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001437-12/ES">2020-001437-12</a>	Random, controlled, open, one-site clinical trial in adult patients with COVID-19 severe pneumonia treated with immunomodulatory drugs	Spain	Y	Y	Drug Repurposing	Cyclosporine, Tocilizumab	Efficacy - Mortality	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001640-26/GB">2020-001640-26</a>	A pilot, open label, phase II clinical trial of nebulised recombinant tissue-Plasminogen Activator (rt-PA)in patients with COVID-19 ARDS: The Plasminogen Activator COVID-19 ARDS (PACA) trial	United Kingdom	N	N	Drug Repurposing	Alteplase	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001659-42/ES">2020-001659-42</a>	Pilot study of antithrombin as prophylaxis of acute respiratory distress syndrome in patients with COVID-19	Spain	Y	N	Cell/Blood based	ND:Human antithrombin	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001270-29/GB">2020-001270-29</a>	An adaptive Phase 2/3, randomized, open-label study assessing efficacy and safety of hydroxychloroquine for hospitalized patients with moderate to severe COVID-19	United Kingdom	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Oxygen parameters	Mild/Moderate Cases, Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001236-10/NL">2020-001236-10</a>	COUNTER-COVID - Oral imatinib to prevent pulmonary vascular leak in COVID-19 &ndash; a randomized, single-blind, placebo controlled, clinical trial in patients with severe COVID-19 disease	Netherlands	Y	N	Drug Repurposing	Imatinib	Efficacy - Other efficacy	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001333-13/FR">2020-001333-13</a>	Dexamethasone associated with hydroxychloroquine vs. hydroxychloroquine alone for the early treatment of severe ARDS caused by COVID-19 : a randomized controlled trial	France	Y	N	Drug Repurposing	Dexamethasone	Efficacy - Mortality	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001023-14/GB">2020-001023-14</a>	A randomised double-blind placebo-controlled trial to determine the safety and efficacy of inhaled SNG001 (IFN-1a for nebulisation) for the treatment of patients with confirmed SARS-CoV-2 infection (COVID-19)	United Kingdom	Y	N	Drug Repurposing	Interferon beta-1a	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001306-35/FR">2020-001306-35</a>	Protective role of inhaled steroids for COVID-19 infection	France	Y	N	Drug Repurposing	Budesonide, Formoterol	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001363-85/DK">2020-001363-85</a>	COVID-19 Prophylaxis with hydroxychloroquine, Vitamin D, and Zinc supplementation in Danish nursing home residents &ndash; a randomized controlled trial	Denmark	Y	N	Drug Repurposing	Hydroxychloroquine, Zinc, Vitamin D	Efficacy - Infection rate (prevention)	General population	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001281-11/FR">2020-001281-11</a>	Evaluation of the concentration/viral effect relationship of hydroxychloroquine in COVID-19 patients in the intensive care unit.	France	N	N	Drug Repurposing	Hydroxychloroquine	Other	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001442-19/ES">2020-001442-19</a>	Pilot, randomized, multicenter, open-label clinical trial of combined use of hydroxychloroquine, azithromycin, and tocilizumab for the treatment of SARS-CoV-2 infection (COVID-19)	Spain	Y	N	Drug Repurposing	Tocilizumab	Efficacy - Mortality	Mild/Moderate Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001031-27/ES">2020-001031-27</a>	Treatment of non-severe confirmed cases of COVID-19 and chemoprophylaxis of their contacts as prevention strategy: a Cluster Randomized Clinical Trial (PEP CoV-2 Study)	Spain	Y	N	Drug Repurposing	Darunavir	Efficacy - Infection rate (prevention)	Mild/Moderate Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001113-21/GB">2020-001113-21</a>	Randomised Evaluation of COVID-19 Therapy (RECOVERY)	United Kingdom	Y	Y	Drug Repurposing	Lopinavir/ritonavir, Dexamethasone, Azithromycin, Lopinavir, Ritonavir	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001622-64/ES">2020-001622-64</a>	OUTPATIENT TREATMENT OF COVID-19 WITH EARLY PULMONARY CORTICOSTEROIDS AS AN OPPORTUNITY TO MODIFY THE COURSE OF THE DISEASE	Spain	Y	N	Drug Repurposing	Prednisone	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000890-25/FR">2020-000890-25</a>	Treatment of Coronavirus SARS-Cov2 Respiratory Infections with Hydroxychloroquine	France	N	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001255-40/ES">2020-001255-40</a>	Sarilumab Treatment In cytoKinE storm caused by infection with COVID-19.	Spain	N	N	Drug Repurposing	Sarilumab	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001614-38/BE">2020-001614-38</a>	Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.	Belgium	Y	N	Drug Repurposing	Azithromycin	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001321-31/ES">2020-001321-31</a>	Prospective, phase II, randomized, open-label, parallel group study to evaluate the efficacy of hydroxychloroquine together with baricitinib, imatinib or early lopinavir / ritonavir in patients with SARS Cov2 pneumonia (COVID-19 HUF)	Spain	Y	Y	Drug Repurposing	Hydroxychloroquine, Baricitinib, Imatinib, Lopinavir/ritonavir	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001420-34/DK">2020-001420-34</a>	Senicapoc in COVID-19 Patients with Severe Respiratory Insufficiency &ndash; A Randomized, Open-Label, Phase II Trial	Denmark	Y	N	Shelved drug or NME	Senicapoc	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001244-26/AT">2020-001244-26</a>	COVID-19: Efficacy of solnatide to treat pulmonary permeability oedema in SARS-Cov-2 positive patients with moderate-to-severe ARDS	Austria	Y	N	Shelved drug or NME	Solnatide	Efficacy - Other efficacy	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001531-27/ES">2020-001531-27</a>	Clinical trial of Sarilumab in adults hospitalized with COVID-19 presenting cytokine release syndrome	Spain	Y	N	Drug Repurposing	Sarilumab	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001246-18/FR">2020-001246-18</a>	Cohort Multiple randomized controlled trials open-label of immune modulatory drugs and other treatments in COVID-19 patients	France	Y	N	Drug Repurposing	Sarilumab, Tocilizumab, Nivolumab, Bevacizumab, Tinzaparin, Hydroxychloroquine, Eculizumab, Baricitinib, Secukinumab	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001310-38/DE">2020-001310-38</a>	A randomized, prospective, open label clinical trial on the use of convalescent plasma compared to best supportive care in patients with severe COVID-19	Germany	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001409-21/ES">2020-001409-21</a>	A prospective, multicenter, randomized, parallel, double-blind, placebo-controlled phase IIb clinical trial to evaluate intravenous infusion of Defibrotide in the prevention and treatment of respiratory distress and cytokine release syndrome in patients with COVID-19.	Spain	Y	N	Drug Repurposing	Defibrotide	Efficacy - Mortality	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001156-18/ES">2020-001156-18</a>	Randomized clinical trial to evaluate the efficacy of different treatments in patients with COVID-19 who require hospitalization	Spain	Y	Y	Drug Repurposing	Lopinavir/ritonavir, Hydroxychloroquine, Azithromycin	Efficacy - Mortality	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-002688-89/ES">2019-002688-89</a>	Phase 1/2 clinical study to assess the feasibility, safety, tolerability and preliminary efficacy of the administration of HCR040, a drug whose active substance is HC016, allogeneic adipose-derived adult mesenchymal stem cells expanded and pulsed with H2O2, in patients with acute respiratory distress syndrome. (included patients COVID-19)	Spain	Y	N	Cell/Blood based	ND:Stem cells	Safety	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001379-34/ES">2020-001379-34</a>	Sedation with sevoflurane versus propofol in patients with Acute Respiratory Distress Syndrome caused by COVID-19 infection	Spain	Y	N	Drug Repurposing	Sevoflurane	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001257-51/DK">2020-001257-51</a>	The Danish Pre-HCQ Dialysis Study:&#13; Hydroxychloroquine for prevention of COVID-19 in dialysis-treated patients with end-stage renal disease -&#13; A multicenter parallel-group open randomized clinical trial&#13;	Denmark	Y	N	Drug Repurposing	Hydroxychloroquine	Other	Other	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001266-11/ES">2020-001266-11</a>	Two-center, randomized, controlled clinical trial with two treatment arms to evaluate the safety and efficacy of intravenous administration of expanded allogeneic adipose tissue adult mesenchymal cells in critically ill patients COVID-19.	Spain	Y	N	Cell/Blood based	ND:MSC	Efficacy - Mortality	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001435-27/FR">2020-001435-27</a>	Home treatment of elderly patients with symptomatic SARS-CoV-2 infection (COVID-19) : a multiarm, multi-stage (MAMS) randomized trial to assess the efficacy and safety of several experimental treatments to reduce the risk of hospitalization or death (COVERAGE trial)	France	Y	Y	Drug Repurposing	Favipiravir, Hydroxychloroquine, Imatinib, Telmisartan	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001406-27/FR">2020-001406-27</a>	Randomized open label trial assessing efficacy and safety of hydroxychloroquine plus azithromycin versus hydroxychloroquine for hospitalized patients with COVID-19	France	Y	N	Drug Repurposing	Azithromycin	Efficacy - WHO scale	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001303-16/FR">2020-001303-16</a>	Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on Survival in Elderly Hospitalized Patients with VIDOC-19 : A Randomized, Multi-Centre, Adaptive, Blinded Study	France	Y	Y	Drug Repurposing	Hydroxychloroquine, Telmisartan, Azithromycin	Efficacy - Mortality	Severe Cases, Other	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001511-25/ES">2020-001511-25</a>	Randomized open-blind controlled trial to study the benefit of Colchicine in Patients with COVID-19	Spain	Y	N	Drug Repurposing	Colchicine	Efficacy - WHO scale	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001307-16/ES">2020-001307-16</a>	Efficacy and Safety of corticoids in patients with adult respiratory distress syndrome (ARDS) secondary to COVID-19.	Spain	Y	N	Drug Repurposing	Methylprednisolone	Efficacy - Mortality	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001591-15/NL">2020-001591-15</a>	Reducing hospital admission of elderly in SARS-CoV-2 pandemic via the induction of trained immunity by bacillus Calmette-Gu&eacute;rin vaccination, a randomized controlled trial. (COVID-19)	Netherlands	Y	N	Drug Repurposing	BCG Vaccine	Efficacy - Other efficacy	Other	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001262-11/ES">2020-001262-11</a>	Randomized, controlled, blinded clinical trial for the evaluator, to evaluate the efficacy and safety of treatment with cyclosporine A (CsA) associated with standard treatment versus standard treatment only in hospitalized patients with confirmed infection by COVID-19	Spain	Y	N	Drug Repurposing	Cyclosporine	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001290-74/ES">2020-001290-74</a>	Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care	Spain	Y	N	Drug Repurposing	Sarilumab	Efficacy - WHO scale	Mild/Moderate Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001413-20/ES">2020-001413-20</a>	Phase 2, randomized, open-label study to compare the efficacy and safety of siltuximab vs. corticosteroids in hospitalized patients with COVID19 pneumonia	Spain	Y	N	Drug Repurposing	Siltuximab, Methylprednisolone	Efficacy - Other efficacy	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001405-23/ES">2020-001405-23</a>	Randomized phase II clinical trial of ruxolitinib plus simvastatin in the prevention and treatment of respiratory failure of COVID-19.Ruxo-Sim-20 clinical trial.	Spain	Y	N	Drug Repurposing	Ruxolitinib, Simvastatin	Efficacy - WHO scale	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001038-36/DE">2020-001038-36</a>	A Multi-site Phase I/II, 2-Part, Dose-Escalation Trial Investigating the Safety and Immunogenicity of four Prophylactic SARS-CoV-2 RNA Vaccines Against COVID-2019 Using Different Dosing Regimens in Healthy Adults	Germany	N	N	Vaccine	BNT162 vaccine	Safety	General population	
<a href="https://ClinicalTrials.gov/show/NCT04333550">NCT04333550</a>	Application of Desferal to Treat COVID-19	Iran	Y	N	Drug Repurposing	Deferoxamine	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04336904">NCT04336904</a>	Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19	Italy	Y	N	Drug Repurposing	Favipiravir	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04354831">NCT04354831</a>	A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection	United States	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04359095">NCT04359095</a>	Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia	Colombia	Y	Y	Drug Repurposing	Hydroxychloroquine, Lopinavir/ritonavir, Azithromycin	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04345445">NCT04345445</a>	Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression	Malaysia	Y	N	Drug Repurposing	Tocilizumab, Methylprednisolone	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04361422">NCT04361422</a>	Isotretinoin in Treatment of COVID-19	Egypt	Y	N	Drug Repurposing	Isotretinoin	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04328272">NCT04328272</a>	Effectiveness of Hydroxychloroquine in Covid-19 Patients	Pakistan	Y	N	Drug Repurposing	Hydroxychloroquine, Azithromycin	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04345679">NCT04345679</a>	Anti COVID-19 Convalescent Plasma Therapy	Hungary	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Viral load	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04347915">NCT04347915</a>	The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19	Korea, Republic of	Y	N	Drug Repurposing	Clevudine, Hydroxychloroquine	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04321421">NCT04321421</a>	Hyperimmune Plasma for Critical Patients With COVID-19	Italy	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04333407">NCT04333407</a>	Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.	United Kingdom	Y	Y	Drug Repurposing	Aspirin, Clopidogrel, Rivaroxaban, Atorvastatin, Omeprazole	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04343755">NCT04343755</a>	Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection	United States	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04333420">NCT04333420</a>	Open-label, Randomized Study of IFX-1 in Patients With Severe COVID-19 Pneumonia	Netherlands	Y	N	Shelved drug or NME	IFX-1	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04324489">NCT04324489</a>	DAS181 for Severe COVID-19: Compassionate Use	China	N	N	Shelved drug or NME	DAS181	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04329611">NCT04329611</a>	ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease	Canada	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04335123">NCT04335123</a>	Study of Open Label Losartan in COVID-19	United States	N	N	Drug Repurposing	Losartan	Safety	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04360356">NCT04360356</a>	Ivermectin and Nitazoxanide Combination Therapy for COVID-19	Egypt	Y	N	Drug Repurposing	Ivermectin, Nitazoxanide	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04350593">NCT04350593</a>	Dapagliflozin in Respiratory Failure in Patients With COVID-19	United States	Y	N	Drug Repurposing	Dapagliflozin	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04352933">NCT04352933</a>	PROLIFIC ChemoprophylaxisTrial (COVID-19)	United Kingdom	Y	Y	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04361318">NCT04361318</a>	Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19	Egypt	Y	N	Drug Repurposing	Hydroxychloroquine, Nitazoxanide	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04347889">NCT04347889</a>	Preventing COVID-19 in Healthcare Workers With HCQ: A RCT	United States	Y	N	Drug Repurposing	Hydroxychloroquine, Ascorbic acid	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04325633">NCT04325633</a>	Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection	France	Y	N	Drug Repurposing	Naproxen	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04339660">NCT04339660</a>	Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia	China	Y	N	Shelved drug or NME	ND:Stem cells	Other	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04321993">NCT04321993</a>	Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients	Canada	Y	Y	Drug Repurposing	Lopinavir/ritonavir, Hydroxychloroquine, Baricitinib	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04357444">NCT04357444</a>	Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19	France	Y	N	Drug Repurposing	IL2	Efficacy - Oxygen parameters	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04317092">NCT04317092</a>	Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)	Italy	N	N	Drug Repurposing	Tocilizumab	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04348071">NCT04348071</a>	Safety and Efficacy of Ruxolitinib for COVID-19	United States	N	N	Drug Repurposing	Ruxolitinib	Safety	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04340232">NCT04340232</a>	Safety and Efficacy of Baricitinib for COVID-19	United States	N	N	Drug Repurposing	Baricitinib	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04362137">NCT04362137</a>	Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)	United States	Y	N	Drug Repurposing	Ruxolitinib	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04354389">NCT04354389</a>	DAS181 for STOP COVID-19	Italy	Y	N	Shelved drug or NME	DAS181	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04346199">NCT04346199</a>	Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. CALAVI (Calquence Against the Virus)	United States	Y	N	Drug Repurposing	Acalabrutinib	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04329832">NCT04329832</a>	Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19	United States	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04324996">NCT04324996</a>	A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19	China	N	Y	Cell/Blood based	ND:T-cells	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04354597">NCT04354597</a>	Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients	Jordan	Y	N	Drug Repurposing	Hydroxychloroquine, Azithromycin	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04359615">NCT04359615</a>	Favipiravir in Hospitalized COVID-19 Patients	Iran	Y	N	Drug Repurposing	Favipiravir	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04359316">NCT04359316</a>	Azithromycin in Hospitalized COVID-19 Patients	Iran	Y	N	Drug Repurposing	Azithromycin	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04352400">NCT04352400</a>	Efficacy of Nafamostat in Covid-19 Patients (RACONA Study)	Italy	Y	N	Drug Repurposing	Nafamostat	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04333355">NCT04333355</a>	Safety in Convalescent Plasma Transfusion to COVID-19	Mexico	N	N	Cell/Blood based	ND:Convalescent plasma	Safety	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04343768">NCT04343768</a>	An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial	Iran	Y	Y	Drug Repurposing	Hydroxychloroquine, Lopinavir/ritonavir, Interferon Beta-1A, Interferon Beta-1B	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04252118">NCT04252118</a>	Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19	China	Y	N	Shelved drug or NME	ND:Stem cells	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04348656">NCT04348656</a>	CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1)	Canada	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04355936">NCT04355936</a>	Telmisartan for Treatment of COVID-19 Patients	Argentina	Y	N	Drug Repurposing	Telmisartan	Efficacy - Oxygen parameters	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04330586">NCT04330586</a>	A Trial of Ciclesonide in Adults With Mild COVID-19	Korea, Republic of	Y	Y	Drug Repurposing	Ciclesonide, Hydroxychloroquine	Efficacy - Viral load	General population	
<a href="https://ClinicalTrials.gov/show/NCT04345523">NCT04345523</a>	Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients	Spain	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - WHO scale	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04350671">NCT04350671</a>	Interferon Beta 1a in Hospitalized COVID-19 Patients	Iran	Y	N	Drug Repurposing	Interferon beta-1A	Efficacy - WHO scale	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04361643">NCT04361643</a>	LENALIDOMIDE COVID-19 TRIAL	Spain	Y	N	Drug Repurposing	Lenalidomide	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04350684">NCT04350684</a>	Umifenovir in Hospitalized COVID-19 Patients	Iran	Y	N	Drug Repurposing	Umifenovir	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04354714">NCT04354714</a>	Ruxolitinib to Combat COVID-19	United States	N	N	Drug Repurposing	Ruxolitinib	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04328285">NCT04328285</a>	Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers	France	Y	Y	Drug Repurposing	Hydroxychloroquine, Lopinavir/ritonavir	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04355897">NCT04355897</a>	CoVID-19 Plasma in Treatment of COVID-19 Patients	United States	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04315298">NCT04315298</a>	Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19	United States	Y	Y	Drug Repurposing	Sarilumab	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04357808">NCT04357808</a>	Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID)	Spain	Y	N	Drug Repurposing	Sarilumab	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04330638">NCT04330638</a>	Treatment of COVID-19 Patients With Anti-interleukin Drugs	Belgium	Y	Y	Drug Repurposing	Anakinra, Siltuximab, Tocilizumab	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04362124">NCT04362124</a>	Performance Evaluation of BCG vs COVID-19	Colombia	Y	N	Drug Repurposing	BCG	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04361214">NCT04361214</a>	Leflunomide in Mild COVID-19 Patients	United States	N	N	Drug Repurposing	Leflunomide	Safety	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04299724">NCT04299724</a>	Safety and Immunity of Covid-19 aAPC Vaccine	China	N	N	Vaccine	ND:Covid-19 aAPC vaccine	Safety	General population, Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04326920">NCT04326920</a>	Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)	Belgium	Y	N	Drug Repurposing	Sargramostim	Efficacy - Oxygen parameters	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04304313">NCT04304313</a>	A Pilot Study of Sildenafil in COVID-19	China	N	N	Drug Repurposing	Sildenafil	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04355247">NCT04355247</a>	Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm	United States	N	N	Drug Repurposing	Methylprednisolone	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04353284">NCT04353284</a>	Camostat Mesylate in COVID-19 Outpatients	United States	Y	N	Drug Repurposing	Camostat	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04356690">NCT04356690</a>	Etoposide in Patients With COVID-19 Infection	United States	N	N	Drug Repurposing	Etoposide	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04351763">NCT04351763</a>	Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms	Poland	Y	Y	Drug Repurposing	Amiodarone, Verapamil	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04354805">NCT04354805</a>	Administration of Chloropromazine as a Treatment for COVID-19	Egypt	Y	N	Drug Repurposing	Chloropromazine	Other	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04340544">NCT04340544</a>	Hydroxychloroquine for the Treatment of Mild COVID-19 Disease	Germany	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04338828">NCT04338828</a>	Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED	United States	Y	N	Drug Repurposing	Nitric Oxide	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04338958">NCT04338958</a>	Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation	Germany	N	N	Drug Repurposing	Ruxolitinib	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04334512">NCT04334512</a>	A Study of Quintuple Therapy to Treat COVID-19 Infection	United States	N	N	Drug Repurposing	Hydroxychloroquine, Azithromycin, Ascorbic acid, Vitamin D, Zinc	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04338074">NCT04338074</a>	TXA and Corona Virus 2019 (COVID19) in Outpatients	United States	Y	N	Drug Repurposing	Tranexamic acid	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04338126">NCT04338126</a>	Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients	United States	Y	N	Drug Repurposing	Tranexamic acid	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04355026">NCT04355026</a>	Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia	Slovenia	Y	N	Drug Repurposing	Bromhexine	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04341675">NCT04341675</a>	Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia	United States	Y	N	Drug Repurposing	Sirolimus	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04353206">NCT04353206</a>	Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure	United States	N	N	Cell/Blood based	ND:Convalescent plasma	Other	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04329923">NCT04329923</a>	The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine)	United States	Y	Y	Drug Repurposing	Hydroxychloroquine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04313322">NCT04313322</a>	Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells	Jordan	N	N	Cell/Blood based	ND:Stem cells	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04355143">NCT04355143</a>	Colchicine to Reduce Myocardial Injury in COVID-19 (COLHEART-19)	United States	Y	N	Drug Repurposing	Colchicine	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04333628">NCT04333628</a>	Chloroquine for Mild Symptomatic and Asymptomatic COVID-19	Israel	Y	Y	Drug Repurposing	Chloroquine	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04304053">NCT04304053</a>	Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention	Spain	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP), Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04353180">NCT04353180</a>	Assessment the Activity Value of 13- Cis-Retinoic Acid(Isotretinoin) in the Treatment of COVID-19	Egypt	Y	Y	Drug Repurposing	Retinoic acid	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04362085">NCT04362085</a>	Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care	Canada	Y	N	Drug Repurposing	Enoxaparin, Dalteparin, Tinzaparin, Heparin	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04351620">NCT04351620</a>	High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19	United States	N	N	Drug Repurposing	Hydroxychloroquine	Safety	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04339426">NCT04339426</a>	Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection	United States	N	N	Drug Repurposing	Atovaquone, Azithromycin	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04334382">NCT04334382</a>	Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19	United States	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04342182">NCT04342182</a>	Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study)	Netherlands	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04343001">NCT04343001</a>	Coronavirus Response - Active Support for Hospitalised Covid-19 Patients	United Kingdom	Y	Y	Drug Repurposing	Aspirin, Losartan, Simvastatin	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04357990">NCT04357990</a>	Kerecis Oral and Nasal Spray for Treating the Symptoms of COVID-19	Iceland	Y	N	Shelved drug or NME	Omega3 Viruxide	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04348500">NCT04348500</a>	Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease	United States	Y	N	Shelved drug or NME	Clazakizumab	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04360980">NCT04360980</a>	The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection	Iran	Y	N	Drug Repurposing	Colchicine	Other	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04335136">NCT04335136</a>	Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19	Denmark	Y	N	Shelved drug or NME	Recombinant Human Angiotensin-converting Enzyme 2	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04359537">NCT04359537</a>	Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19	Pakistan	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04362189">NCT04362189</a>	Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19	United States	Y	Y	Cell/Blood based	ND:Stem cells	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04343092">NCT04343092</a>	Ivermectin Adjuvant to Hydroxychloroquin and Azithromycine in COVID19 Patients	Iraq	Y	N	Drug Repurposing	Ivermectin	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04359511">NCT04359511</a>	Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia	France	Y	N	Drug Repurposing	Prednisone	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04331795">NCT04331795</a>	Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis	United States	N	Y	Drug Repurposing	Tocilizumab	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04333225">NCT04333225</a>	Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers	United States	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04351724">NCT04351724</a>	Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)	Austria	Y	Y	Drug Repurposing, Shelved drug or NME	Hydroxychloroquine, Chloroquine, Lopinavir/ritonavir, Rivaroxaban, Candesartan, Clazakizumab	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04344444">NCT04344444</a>	Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease	United States	Y	Y	Drug Repurposing	Hydroxychloroquine, Azithromycin	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04352465">NCT04352465</a>	Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients	Brazil	N	N	Shelved drug or NME	Methotrexate nano-formulation	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04352751">NCT04352751</a>	Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020	Pakistan	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04307693">NCT04307693</a>	Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)	Korea, Republic of	Y	Y	Drug Repurposing	Hydroxychloroquine, Lopinavir/ritonavir	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04329650">NCT04329650</a>	Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia	Spain	Y	N	Drug Repurposing	Siltuximab, Methylprednisolone	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04345692">NCT04345692</a>	A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients	United States	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - WHO scale	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04362332">NCT04362332</a>	Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19	Netherlands	Y	Y	Drug Repurposing	Chloroquine, Hydroxychloroquine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04323631">NCT04323631</a>	Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death	Israel	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Mortality	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04331834">NCT04331834</a>	Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic	Spain	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04331470">NCT04331470</a>	Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19	Iran	Y	N	Drug Repurposing	Levamisole, Budesonide/formoterol	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04356677">NCT04356677</a>	Study to Evaluate the Safety and Efficacy of VIRAZOLE  in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19	United States	N	N	Drug Repurposing	Ribavirin	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04350320">NCT04350320</a>	Randomized Open-blind Controlled Trial to Study the Benefit of Colchicine in Patients With COVID-19	Spain	Y	N	Drug Repurposing	Colchicine	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04313023">NCT04313023</a>	The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2	United States	Y	N	Shelved drug or NME	PUL-042	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04336254">NCT04336254</a>	Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients	China	Y	N	Cell/Blood based	ND:Stem cells	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04292899">NCT04292899</a>	Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734 ) in Participants With Severe Coronavirus Disease (COVID-19)	United States	N	N	Shelved drug or NME	Remdesivir	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04332094">NCT04332094</a>	Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19	Brazil	Y	N	Drug Repurposing	Tocilizumab	Efficacy - Mortality	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04312997">NCT04312997</a>	The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection	United States	Y	N	Shelved drug or NME	PUL-042	Efficacy - WHO scale	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04334980">NCT04334980</a>	Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19	Canada	Y	Y	Vaccine	bacTRL-Spike vaccine	Safety	Other	
<a href="https://ClinicalTrials.gov/show/NCT04348409">NCT04348409</a>	Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19	Brazil	Y	N	Drug Repurposing	Nitazoxanide	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04353518">NCT04353518</a>	Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19	India	Y	N	Shelved drug or NME	Mycobacterium	Efficacy - Infection rate (prevention)	General population	
<a href="https://ClinicalTrials.gov/show/NCT04360551">NCT04360551</a>	Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients	United States	Y	N	Drug Repurposing	Telmisartan	Efficacy - WHO scale	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04343989">NCT04343989</a>	A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection	United States	Y	Y	Shelved drug or NME	Clazakizumab	Safety	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04348474">NCT04348474</a>	Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19	Brazil	N	N	Drug Repurposing	Hydroxychloroquine, Azithromycin	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04358809">NCT04358809</a>	Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill	India	Y	N	Vaccine	heat killed (autoclaved) Mycobacterium	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04348435">NCT04348435</a>	A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19	United States	Y	Y	Cell/Blood based	ND:Stem cells	Efficacy - Other efficacy	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04329572">NCT04329572</a>	Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19	Brazil	N	N	Drug Repurposing	Hydroxychloroquine, Azithromycin	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04276896">NCT04276896</a>	Immunity and Safety of Covid-19 Synthetic Minigene Vaccine	China	N	N	Cell/Blood based	ND:T-cells	Efficacy - WHO scale	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04292730">NCT04292730</a>	Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734 ) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment	United States	Y	Y	Shelved drug or NME	Remdesivir	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04358549">NCT04358549</a>	Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19	United States	Y	N	Drug Repurposing	Favipiravir	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04360824">NCT04360824</a>	Covid-19 Associated Coagulopathy	United States	Y	N	Drug Repurposing	Enoxaparin	Efficacy - Mortality	General population, Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04349410">NCT04349410</a>	The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol	United States	Y	Y	Drug Repurposing, Shelved drug or NME, Cell/Blood based	Hydroxychloroquine, Azithromycin, Doxycycline, Clindamycin, Primaquine, Remdesivir, Tocilizumab, Methylprednisolone, Losartan, ND:Convalescent plasma, Interferon alpha-2b	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04346615">NCT04346615</a>	Safety and Efficacy Trial of Vazegepant Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen	United States	Y	N	Shelved drug or NME	Vazegepant	Safety	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04328493">NCT04328493</a>	The Vietnam Chloroquine Treatment on COVID-19	Viet Nam	Y	N	Drug Repurposing	Chloroquine	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04354870">NCT04354870</a>	COVID-19 PrEP HCW HCQ Study	United States	N	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04305106">NCT04305106</a>	Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT	China	Y	N	Drug Repurposing	Bevacizumab	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04315987">NCT04315987</a>	NestCell  Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia	Brazil	N	N	Cell/Blood based	ND:Stem cells	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04244591">NCT04244591</a>	Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure	China	Y	N	Drug Repurposing	Methylprednisolone	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04320615">NCT04320615</a>	A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia	United States	Y	N	Drug Repurposing	Tocilizumab	Efficacy - WHO scale	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04323514">NCT04323514</a>	Use of Ascorbic Acid in Patients With COVID 19	Italy	N	N	Drug Repurposing	Ascorbic acid	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04315896">NCT04315896</a>	Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial)	Mexico	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04273646">NCT04273646</a>	Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19	China	N	N	Cell/Blood based	ND:Stem cells	Efficacy - Oxygen parameters	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04273529">NCT04273529</a>	The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia	China	Y	N	Drug Repurposing	Thalidomide	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04273581">NCT04273581</a>	The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19	China	Y	N	Drug Repurposing	Thalidomide	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04325061">NCT04325061</a>	Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19	Spain	Y	N	Drug Repurposing	Dexamethasone	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04342663">NCT04342663</a>	A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection	United States	Y	N	Drug Repurposing	Fluvoxamine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04342221">NCT04342221</a>	Hydroxychloroquine for COVID-19	Germany	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04332107">NCT04332107</a>	Azithromycin for COVID-19 Treatment in Outpatients Nationwide	United States	Y	N	Drug Repurposing	Azithromycin	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04344730">NCT04344730</a>	Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia	France	Y	Y	Drug Repurposing, Other	Dexamethasone, ND:Procedure	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04341207">NCT04341207</a>	Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients	France	N	N	Drug Repurposing	Hydroxychloroquine, Azithromycin	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04335201">NCT04335201</a>	Defibrotide in COVID-19 Pneumonia	Italy	N	N	Drug Repurposing	Defibrotide	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04355767">NCT04355767</a>	Convalescent Plasma vs. Placebo in Emergency Room Patients With COVID-19	United States	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04328441">NCT04328441</a>	Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine	Netherlands	Y	N	Drug Repurposing, Vaccine	BCG Vaccine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04334044">NCT04334044</a>	Treatment of SARS Caused by COVID-19 With Ruxolitinib	Mexico	N	N	Drug Repurposing	Ruxolitinib	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04352608">NCT04352608</a>	Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)	China	Y	Y	Vaccine	ND:Vaccine	Safety	General population	
<a href="https://ClinicalTrials.gov/show/NCT04359680">NCT04359680</a>	Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- or Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers	United States	Y	N	Drug Repurposing	Nitazoxanide	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04353271">NCT04353271</a>	Trial of Hydroxychloroquine In Covid-19 Kinetics	United States	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04344457">NCT04344457</a>	Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19	United States	N	N	Drug Repurposing	Hydroxychloroquine, Indomethacin, Azithromycin	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04343248">NCT04343248</a>	Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)	United States	Y	N	Drug Repurposing	Nitazoxanide	Efficacy - Infection rate (prevention)	Other	
<a href="https://ClinicalTrials.gov/show/NCT04252664">NCT04252664</a>	A Trial of Remdesivir in Adults With Mild and Moderate COVID-19	China	Y	N	Shelved drug or NME	Remdesivir	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04280588">NCT04280588</a>	Fingolimod in COVID-19	China	Y	N	Drug Repurposing	Fingolimod	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04351919">NCT04351919</a>	Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+)	Tunisia	N	N	Drug Repurposing	Hydroxychloroquine, Azithromycin	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04358068">NCT04358068</a>	Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19	United States	Y	N	Drug Repurposing	Hydroxychloroquine, Azithromycin	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04336332">NCT04336332</a>	Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19	United States	Y	Y	Drug Repurposing	Hydroxychloroquine, Azithromycin	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04334005">NCT04334005</a>	Vitamin D on Prevention and Treatment of COVID-19	Spain	Y	N	Drug Repurposing	Vitamin D	Efficacy - Mortality	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04351152">NCT04351152</a>	Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Hospitalized Patients With COVID-19 Pneumonia	United States	Y	N	Shelved drug or NME	Lenzilumab	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04348877">NCT04348877</a>	Plasma Rich Antibodies From Recovered Patients From COVID19	Egypt	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Viral load	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04349241">NCT04349241</a>	Efficacy and Safety of Favipiravir in Management of COVID-19	Egypt	Y	N	Drug Repurposing	Favipiravir	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04303299">NCT04303299</a>	Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Hydroxychloroquine for Treatment of COVID-19 : A Randomized Control Trial	Thailand	Y	Y	Drug Repurposing, Shelved drug or NME	Oseltamivir, Hydroxychloroquine, Darunavir, Lopinavir/ritonavir, Favipiravir	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04331600">NCT04331600</a>	ChloroQUine As antiviRal treAtmeNT In coroNavirus infEction 2020	Poland	Y	N	Drug Repurposing	Chloroquine	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04357457">NCT04357457</a>	Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia	France	Y	N	Drug Repurposing	Almitrine	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04360876">NCT04360876</a>	Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial	United States	Y	N	Drug Repurposing	Dexamethasone	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04344951">NCT04344951</a>	Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial	Greece	N	N	Drug Repurposing	Chloroquine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04360122">NCT04360122</a>	Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19	Egypt	Y	N	Drug Repurposing	Levamisole, Isoprinosine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04347681">NCT04347681</a>	Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19	Saudi Arabia	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04341116">NCT04341116</a>	Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)	United States	Y	Y	Shelved drug or NME	TJ003234 (Anti-GM-CSF Monoclonal Antibody)	Efficacy - WHO scale	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04342897">NCT04342897</a>	A Study of LY3127804 in Participants With COVID-19	United States	Y	N	Shelved drug or NME	LY3127804	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04350931">NCT04350931</a>	Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19	Egypt	Y	N	Drug Repurposing	BCG Vaccine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04341389">NCT04341389</a>	A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector)	China	Y	Y	Vaccine	ND:Vaccine	Safety	General population	
<a href="https://ClinicalTrials.gov/show/NCT04348513">NCT04348513</a>	Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection	Greece	Y	N	Drug Repurposing	Triiodothyronine	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04345653">NCT04345653</a>	Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers	United States	N	N	Drug Repurposing	Hydroxychloroquine	Other	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04350736">NCT04350736</a>	First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19	United Kingdom	Y	N	Shelved drug or NME	TD-0903	Safety	General population	
<a href="https://ClinicalTrials.gov/show/NCT04317040">NCT04317040</a>	CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment	United States	Y	N	Shelved drug or NME	CD24Fc	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04326790">NCT04326790</a>	The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention	Greece	Y	N	Drug Repurposing	Colchicine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04345276">NCT04345276</a>	Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection	China	N	N	Drug Repurposing, Shelved drug or NME	Danoprevir, Ritonavir	Efficacy - Oxygen parameters	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04291729">NCT04291729</a>	Evaluation of Ganovo (Danoprevir ) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection	China	N	N	Drug Repurposing, Shelved drug or NME	Danoprevir, Ritonavir, Interferon(NOS)	Efficacy - Oxygen parameters	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04339816">NCT04339816</a>	Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial	Czech Republic	Y	N	Drug Repurposing	Azithromycin, Hydroxychloroquine	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04346368">NCT04346368</a>	Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19)	China	Y	N	Cell/Blood based	ND:Stem cells	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04359654">NCT04359654</a>	Nebulised Dornase Alfa for Treatment of COVID-19	United Kingdom	Y	N	Drug Repurposing	Dornase alfa	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04331054">NCT04331054</a>	Protective Role of Inhaled Steroids for Covid-19 Infection	France	Y	N	Drug Repurposing	Budesonide/formoterol	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04288102">NCT04288102</a>	Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019(COVID-19)	China	Y	N	Cell/Blood based	ND:Stem cells	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04358406">NCT04358406</a>	Rhu-pGSN for Severe Covid-19 Pneumonia	United States	Y	N	Shelved drug or NME	Recombinant human plasma gelsolin	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04286503">NCT04286503</a>	The Clinical Study of Carrimycin on Treatment Patients With COVID-19	China	Y	N	Shelved drug or NME	Carrimycin	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04335071">NCT04335071</a>	Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)	Switzerland	Y	N	Drug Repurposing	Tocilizumab	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04347512">NCT04347512</a>	EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA	France	Y	N	Drug Repurposing	Hydroxychloroquine, Azithromycin	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04351243">NCT04351243</a>	A Study to Assess the Efficacy and Safety of of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19.	United States	Y	N	Shelved drug or NME	Gimsilumab	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04333472">NCT04333472</a>	Piclidenoson for Treatment of COVID-19	Israel	Y	N	Shelved drug or NME	Piclidenoson	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04352803">NCT04352803</a>	Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease	United States	N	N	Cell/Blood based	ND:MSCs	Safety	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04348305">NCT04348305</a>	Hydrocortisone for COVID-19 and Severe Hypoxia	Denmark	Y	N	Drug Repurposing	Hydrocortisone	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04350580">NCT04350580</a>	Polyvalent Immunoglobulin in COVID-19 Related ARds	France	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04353336">NCT04353336</a>	Efficacay of Chloroquine in COVID-19 Treatment	Egypt	Y	N	Drug Repurposing	Chloroquine	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04353674">NCT04353674</a>	Modulation of Hyperinflammation in COVID-19	United States	Y	N	Cell/Blood based	ND:Neutrophil modulation	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04335305">NCT04335305</a>	Checkpoint Blockade in COVID-19 Pandemic	Spain	Y	N	Drug Repurposing	Pembrolizumab, Tocilizumab	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04273321">NCT04273321</a>	Efficacy and Safety of Corticosteroids in COVID-19	China	Y	N	Drug Repurposing	Methylprednisolone	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04343976">NCT04343976</a>	Pegylated Interferon Lambda Treatment for COVID-19	United States	Y	N	Shelved drug or NME	Peg-Interferon lambda	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04351490">NCT04351490</a>	Impact of Zinc and Vitamin D3 Supplementation on the Survival of Aged Patients Infected With COVID-19	France	Y	N	Drug Repurposing	Zinc, Vitamin D3	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04360759">NCT04360759</a>	Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19	South Africa	Y	N	Drug Repurposing	Chloroquine, Hydroxychloroquine	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04331665">NCT04331665</a>	Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia	Canada	N	N	Drug Repurposing	Ruxolitinib	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04362111">NCT04362111</a>	Early Identification and Treatment of Cytokine Storm Syndrome in Covid-19	United States	Y	N	Drug Repurposing	Anakinra	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04318444">NCT04318444</a>	Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)	United States	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04318015">NCT04318015</a>	Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial)	Mexico	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04341038">NCT04341038</a>	Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury	Spain	Y	N	Drug Repurposing	Methylprednisolone, Tacrolimus	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04330144">NCT04330144</a>	Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial)	Korea, Republic of	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT03891420">NCT03891420</a>	A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19	Brazil	Y	N	Shelved drug or NME	Galidesivir	Safety	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04313127">NCT04313127</a>	Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults	China	N	N	Vaccine	ND:Vaccine	Safety	General population	
<a href="https://ClinicalTrials.gov/show/NCT04343963">NCT04343963</a>	Pyridostigmine in Severe SARS-CoV-2 Infection	Mexico	Y	N	Drug Repurposing	Pyridostigmine	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04333732">NCT04333732</a>	CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION	United States	Y	Y	Drug Repurposing	Chloroquine, Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04335552">NCT04335552</a>	Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection	United States	Y	Y	Drug Repurposing	Hydroxychloroquine, Azithromycin	Efficacy - WHO scale	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04354428">NCT04354428</a>	Treatment for SARS-CoV-2 in High-Risk Adult Outpatients	United States	Y	Y	Drug Repurposing	Hydroxychloroquine, Ascorbic acid, Folic acid, Azithromycin	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04361032">NCT04361032</a>	Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia	Tunisia	Y	N	Drug Repurposing	Tocilizumab, Deferoxamine	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04356534">NCT04356534</a>	Convalescent Plasma Trial in COVID -19 Patients	Ireland	Y	N	Cell/Blood based	ND:Covalescent plasma	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04356937">NCT04356937</a>	Efficacy of Tocilizumab on Patients With COVID-19	United States	Y	N	Drug Repurposing	Tocilizumab	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04359862">NCT04359862</a>	Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection	Spain	Y	N	Drug Repurposing	Sevoflurane	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04334460">NCT04334460</a>	Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects	United States	Y	N	Shelved drug or NME	BLD-2660	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04338698">NCT04338698</a>	Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT	Pakistan	Y	Y	Drug Repurposing	Hydroxychloroquine, Oseltamivir, Azithromycin	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04349631">NCT04349631</a>	A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19	United States	N	N	Cell/Blood based	ND:Stem cells	Efficacy - Other efficacy	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04261517">NCT04261517</a>	Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19	China	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04319731">NCT04319731</a>	A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure	United States	N	N	Cell/Blood based	ND:Amniotic fluid	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04344600">NCT04344600</a>	Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 Infection	United States	Y	N	Shelved drug or NME	Peg-Interferon lambda-1a	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04257656">NCT04257656</a>	A Trial of Remdesivir in Adults With Severe COVID-19	China	Y	N	Shelved drug or NME	Remdesivir	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04357028">NCT04357028</a>	Measles Vaccine in HCW	Egypt	Y	N	Drug Repurposing, Vaccine	Measles Vaccine	Efficacy - Infection rate (prevention)	General population	
<a href="https://ClinicalTrials.gov/show/NCT04328012">NCT04328012</a>	COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2	United States	Y	Y	Drug Repurposing	Lopinavir/ritonavir, Hydroxychloroquine, Losartan	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04351191">NCT04351191</a>	PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds	Pakistan	Y	Y	Drug Repurposing	Hydroxychloroquine, Chloroquine	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04335032">NCT04335032</a>	EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)	United Kingdom	N	N	Shelved drug or NME	Eicosapentaenoic acid	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04356508">NCT04356508</a>	COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1	Hong Kong	N	N	Drug Repurposing	Nivolumab	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04335786">NCT04335786</a>	Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease	Netherlands	Y	N	Drug Repurposing	Valsartan	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04324021">NCT04324021</a>	Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.	Italy	Y	Y	Drug Repurposing	Emapalumab, Anakinra	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04333914">NCT04333914</a>	Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection	France	Y	Y	Drug Repurposing, Shelved drug or NME	GNS651, Nivolumab, Tocilizumab	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04345848">NCT04345848</a>	Preventing COVID-19 Complications With Low- and High-dose Anticoagulation	Switzerland	Y	N	Drug Repurposing	Enoxaparin	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04341441">NCT04341441</a>	Will Hydroxychloroquine Impede or Prevent COVID-19	United States	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04344379">NCT04344379</a>	Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus	France	Y	Y	Drug Repurposing	Hydroxychloroquine, Azithromycin	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04357860">NCT04357860</a>	Clinical Trial of Sarilumab in Adults With COVID-19	Spain	Y	N	Drug Repurposing	Sarilumab	Efficacy - Oxygen parameters	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04345601">NCT04345601</a>	Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)	United States	N	N	Cell/Blood based	ND:MSC	Safety	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04268537">NCT04268537</a>	Immunoregulatory Therapy for 2019-nCoV	China	Y	Y	Drug Repurposing	Anti-PD-1(NOS), Thymosin alpha	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04350086">NCT04350086</a>	Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection	France	N	N	Drug Repurposing	Dexmedetomidine	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04355728">NCT04355728</a>	Use of UC-MSCs for COVID-19 Patients	United States	Y	N	Cell/Blood based	ND:MSC	Safety	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04330495">NCT04330495</a>	Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection	Spain	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Other	
<a href="https://ClinicalTrials.gov/show/NCT04303507">NCT04303507</a>	Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting	United Kingdom	Y	N	Drug Repurposing	Chloroquine, Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04350450">NCT04350450</a>	Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore	United States	N	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04354441">NCT04354441</a>	Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women	United States	Y	N	Drug Repurposing	Hydoxychloroquine	Efficacy - Other efficacy	Other	
<a href="https://ClinicalTrials.gov/show/NCT04273763">NCT04273763</a>	Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)	China	Y	N	Drug Repurposing	Bromhexine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04328961">NCT04328961</a>	Hydroxychloroquine for COVID-19 PEP	United States	Y	Y	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	General population	
<a href="https://ClinicalTrials.gov/show/NCT04347226">NCT04347226</a>	Anti-Interleukin-8 (Anti-IL-8) for Cancer Patients With COVID-19	United States	Y	N	Shelved drug or NME	BMS-986253	Efficacy - WHO scale	Other	
<a href="https://ClinicalTrials.gov/show/NCT04261426">NCT04261426</a>	The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia	China	N	N	Cell/Blood based	ND:Immunoglobulin	Efficacy - WHO scale	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04327206">NCT04327206</a>	BCG Vaccination to Protect Healthcare Workers Against COVID-19	Australia	Y	N	Drug Repurposing, Vaccine	BCG Vaccine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04255017">NCT04255017</a>	A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia	China	Y	Y	Drug Repurposing	Oseltamivir, Abidol, Lopinavir/ritonavir	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04254874">NCT04254874</a>	A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia	China	Y	N	Drug Repurposing	Peg-Interferon alpha-2b	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04339712">NCT04339712</a>	Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction	Greece	N	N	Drug Repurposing	Anakinra, Tocilizumab	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04261270">NCT04261270</a>	A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia	China	N	Y	Drug Repurposing, Shelved drug or NME	Ritonavir, Oseltamivir, ASC09F	Efficacy - Oxygen parameters	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04356482">NCT04356482</a>	CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19	Mexico	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04346667">NCT04346667</a>	Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds	Pakistan	Y	Y	Drug Repurposing	Hydroxychloroquine, Chloroquine	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04332042">NCT04332042</a>	TOFAcitinib in SARS-CoV2 Pneumonia	Italy	Y	N	Drug Repurposing	Tofacitinib	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04357366">NCT04357366</a>	suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE)	Greece	N	N	Drug Repurposing	Anakinra, Trimethoprim/sulfamethoxazole	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04357782">NCT04357782</a>	Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation	United States	N	N	Drug Repurposing	Ascorbic acid	Safety	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04362176">NCT04362176</a>	Passive Immunity Trial of Nashville II	United States	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04321616">NCT04321616</a>	The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients	Norway	Y	Y	Drug Repurposing, Shelved drug or NME	Hydroxychloroquine, Remdesivir	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04263402">NCT04263402</a>	The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia	China	N	Y	Drug Repurposing	Methylprednisolone	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04343261">NCT04343261</a>	Convalescent Plasma in the Treatment of COVID 19	United States	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04344184">NCT04344184</a>	Early Infusion of Vitamin C for Treatment of Novel COVID-19 Acute Lung Injury (EVICT-CORONA-ALI)	United States	Y	N	Drug Repurposing	Ascorbic acid	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04353128">NCT04353128</a>	Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.	Spain	Y	N	Drug Repurposing	Melatonin	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04333368">NCT04333368</a>	Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS	France	Y	N	Cell/Blood based	ND:Stem cells	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04349228">NCT04349228</a>	Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals	Tunisia	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04352946">NCT04352946</a>	HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial	United States	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04331613">NCT04331613</a>	Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS	China	N	N	Cell/Blood based	ND:Stem cells	Safety	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04334967">NCT04334967</a>	Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care	United States	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04349592">NCT04349592</a>	Qatar Prospective RCT Of Therapy Eliminating Covid Transmission	Qatar	Y	N	Drug Repurposing	Azithromycin	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04340050">NCT04340050</a>	COVID-19 Convalescent Plasma	United States	N	N	Cell/Blood based	ND:Convalescent plasma	Other	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04264858">NCT04264858</a>	Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients	China	Y	N	Cell/Blood based	ND:Immunoglobulin	Efficacy - WHO scale	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04332666">NCT04332666</a>	Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial	Belgium	Y	N	Drug Repurposing	Angiotensin 1-7	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04351516">NCT04351516</a>	Test and Treat COVID 65plus+	Germany	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04332991">NCT04332991</a>	Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease	United States	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - WHO scale	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04354259">NCT04354259</a>	Interferon Lambda for Immediate Antiviral Therapy at Diagnosis	Canada	Y	Y	Shelved drug or NME	Interferon lambda	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04357106">NCT04357106</a>	COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma	Mexico	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04334148">NCT04334148</a>	Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine	United States	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04333589">NCT04333589</a>	Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive	China	Y	N	Drug Repurposing	Favipiravir	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04328480">NCT04328480</a>	The ECLA PHRI COLCOVID Trial	Argentina	Y	N	Drug Repurposing	Colchicine	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04310228">NCT04310228</a>	Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019	China	Y	Y	Drug Repurposing	Favipiravir, Tocilizumab	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04302519">NCT04302519</a>	Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells	China	N	N	Cell/Blood based	ND:Stem cells	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04320238">NCT04320238</a>	Experimental Trial of rhIFNa Nasal Drops to Prevent 2019-nCOV in Medical Staff	China	N	Y	Drug Repurposing	Interferon alpha, Thymosin alpha	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04298060">NCT04298060</a>	DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)	China	Y	Y	Shelved drug or NME	DAS181	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04343651">NCT04343651</a>	Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19	United States	Y	N	Shelved drug or NME	Leronlimab	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04342650">NCT04342650</a>	Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection	Brazil	Y	N	Drug Repurposing	Chloroquine	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04361461">NCT04361461</a>	Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)	Brazil	Y	N	Drug Repurposing	Hydroxychloroquine, Azythromycin	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04285190">NCT04285190</a>	The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19	China	Y	N	Drug Repurposing	T89	Efficacy - Oxygen parameters	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04324606">NCT04324606</a>	A Study of a Candidate COVID-19 Vaccine (COV001)	United Kingdom	N	Y	Vaccine	ND:ChAdOx1 vaccine	Safety	General population	
<a href="https://ClinicalTrials.gov/show/NCT04321096">NCT04321096</a>	The Impact of Camostat Mesilate on COVID-19 Infection	Denmark	Y	N	Drug Repurposing	Camostat	Efficacy - WHO scale	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04347239">NCT04347239</a>	Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)	United States	Y	N	Shelved drug or NME	Leronlimab	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04361474">NCT04361474</a>	Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity	France	Y	N	Drug Repurposing	Budesonide	Other	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04355429">NCT04355429</a>	Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID)	France	Y	N	Drug Repurposing	Captopril	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04355962">NCT04355962</a>	Sevoflurane in COVID-19 ARDS (SevCov)	Switzerland	Y	N	Drug Repurposing	Sevoflurane	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04323800">NCT04323800</a>	Efficacy and Safety Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune Plasma) Among Adults Exposed to COVID-19	United States	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - WHO scale	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04349098">NCT04349098</a>	Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection	United States	Y	N	Drug Repurposing	Selinexor	Efficacy - WHO scale	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04332380">NCT04332380</a>	Convalescent Plasma for Patients With COVID-19: A Pilot Study	Colombia	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04355676">NCT04355676</a>	Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19	United States	N	N	Drug Repurposing	Selinexor	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04332835">NCT04332835</a>	Convalescent Plasma for Patients With COVID-19: A Randomized, Open Label, Parallel, Controlled Clinical Study	Colombia	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04312009">NCT04312009</a>	Losartan for Patients With COVID-19 Requiring Hospitalization	United States	Y	N	Drug Repurposing	Losartan	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases, Mild/Moderate Cases, Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04315948">NCT04315948</a>	Trial of Treatments for COVID-19 in Hospitalized Adults	France	Y	Y	Drug Repurposing, Shelved drug or NME	Remdesivir, Lopinavir/ritonavir, Interferon beta-1a, Hydroxychloroquine	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04311177">NCT04311177</a>	Losartan for Patients With COVID-19 Not Requiring Hospitalization	United States	Y	N	Drug Repurposing	Losartan	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04335084">NCT04335084</a>	A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection	United States	N	N	Drug Repurposing	Hydroxychloroquine, Ascorbic acid, Vitamin D, Zinc	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04260594">NCT04260594</a>	Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus	China	Y	N	Drug Repurposing	Umifenovir	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04336748">NCT04336748</a>	HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers	Austria	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04341935">NCT04341935</a>	Effects of DPP4 Inhibition on COVID-19	United States	Y	N	Drug Repurposing	Linagliptin	Other	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04275414">NCT04275414</a>	Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia	China	N	N	Drug Repurposing	Bevacizumab	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04360096">NCT04360096</a>	Inhaled Aviptadil for the Treatment of Non-Acute Lung Injury in COVID-19	United States	Y	N	Shelved drug or NME	Aviptadil	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04327349">NCT04327349</a>	Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial	Iran	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04342169">NCT04342169</a>	University of Utah COVID-19 Hydrochloroquine Trial	United States	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04357730">NCT04357730</a>	STudy of Alteplase for Respiratory Failure in SARS-Cov2 (COVID-19)	United States	Y	N	Drug Repurposing	Alteplase	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04311697">NCT04311697</a>	Intravenous Aviptadil for COVID-19 Associated Acute Respiratory Distress	United States	Y	N	Shelved drug or NME	Aviptadil	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04358081">NCT04358081</a>	Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease	United States	Y	Y	Drug Repurposing	Hydroxychloroquine, Azithromycin	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04346589">NCT04346589</a>	Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients	Italy	N	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04340349">NCT04340349</a>	Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals	Mexico	Y	N	Drug Repurposing	Hydroxychloroquine, Bromhexine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT03042143">NCT03042143</a>	Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST) (COVID-19)	United Kingdom	Y	N	Cell/Blood based	ND:Stem cells	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04359810">NCT04359810</a>	Plasma Therapy of COVID-19 in Critically Ill Patients	United States	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04252274">NCT04252274</a>	Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19	China	Y	N	Drug Repurposing	Darunavir, Cobicistat	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04305457">NCT04305457</a>	Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19	United States	Y	N	Drug Repurposing	Nitric oxide	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04320277">NCT04320277</a>	Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.	Italy	N	N	Drug Repurposing	Baricitinib	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04342156">NCT04342156</a>	Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19	Singapore	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04327401">NCT04327401</a>	COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III	Brazil	Y	N	Drug Repurposing	Dexamethasone	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04321278">NCT04321278</a>	Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)	Brazil	Y	Y	Drug Repurposing	Azithromycin, Hydroxychloroquine	Efficacy - WHO scale	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04280705">NCT04280705</a>	Adaptive COVID-19 Treatment Trial (ACTT)	United States	Y	N	Shelved drug or NME	Remdesivir	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04323592">NCT04323592</a>	Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome	Italy	N	N	Drug Repurposing	Methylprednisolone	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04345614">NCT04345614</a>	A Study of CM4620-Injectable Emulsion (IE) in Patients With Severe COVID-19 Pneumonia	United States	Y	N	Shelved drug or NME	CM4620	Efficacy - WHO scale	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04359290">NCT04359290</a>	Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS	Germany	N	N	Drug Repurposing	Ruxolitinib	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT02735707">NCT02735707</a>	Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia	Netherlands	Y	Y	Drug Repurposing	Hydrocortisone, Ceftriaxone, Moxifloxacin, Levofloxacin, Piperacillin-tazobactam, Ceftaroline, Amoxicillin-clavulanate, Oseltamivir, Lopinavir/ritonavir, Hydroxychloroquine, Interferon-beta1a, Anakinra, Tocilizumab, Sarilumab	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04324463">NCT04324463</a>	Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial	Canada	Y	N	Drug Repurposing	Azithromycin, Chloroquine, Hydoxychloroquine, Interferon-beta	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04321174">NCT04321174</a>	COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir	Canada	Y	N	Drug Repurposing	Lopinavir/ritonavir	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04354155">NCT04354155</a>	COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial	United States	N	N	Drug Repurposing	Enoxaparin	Safety	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04358783">NCT04358783</a>	Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia	Mexico	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Mortality	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04334629">NCT04334629</a>	LIBA Trial in COVID-19	United Kingdom	Y	N	Drug Repurposing	Ibuprofen	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04345887">NCT04345887</a>	Spironolactone in Covid-19 Induced ARDS	Turkey	Y	N	Drug Repurposing	Spironolactone	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04359329">NCT04359329</a>	Estrogen Patch for COVID-19 Symptoms	United States	Y	N	Drug Repurposing	Estrogen patch	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04322344">NCT04322344</a>	Escin in Patients With Covid-19 Infection	Italy	Y	Y	Drug Repurposing	Escin	Efficacy - Mortality	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04351295">NCT04351295</a>	Efficacy of Faviprevir in COVID-19 Treatment	Egypt	Y	N	Drug Repurposing	Favipiravir	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04312243">NCT04312243</a>	NO Prevention of COVID-19 for Healthcare Providers	United States	Y	N	Drug Repurposing	Nitric oxide	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04322565">NCT04322565</a>	Colchicine Counteracting Inflammation in COVID-19 Pneumonia	Italy	Y	N	Drug Repurposing	Colchicine	Efficacy - WHO scale	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04345406">NCT04345406</a>	Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19	Egypt	Y	N	Drug Repurposing	Captopril, Enalapril	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04345419">NCT04345419</a>	A Real-life Experience on Treatment of Patients With COVID 19	Egypt	Y	Y	Drug Repurposing	Chloroquine, Favipiravir, Nitazoxanide, Ivermectin, Niclosamide	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04357613">NCT04357613</a>	IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS.	France	Y	N	Drug Repurposing	Imatinib	Safety	Other	
<a href="https://ClinicalTrials.gov/show/NCT04344041">NCT04344041</a>	COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial)	France	Y	N	Drug Repurposing	Vitamin D	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases, Other	
<a href="https://ClinicalTrials.gov/show/NCT04355637">NCT04355637</a>	Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia	Spain	Y	N	Drug Repurposing	Budesonide	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04333654">NCT04333654</a>	Hydroxychloroquine in Outpatient Adults With COVID-19	United States	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04351347">NCT04351347</a>	The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment	Egypt	Y	N	Drug Repurposing	Ivermectin, Nitazoxanide	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04348461">NCT04348461</a>	BAttLe Against COVID-19 Using MesenchYmal Stromal Cells	Spain	Y	N	Cell/Blood based	ND:MSC	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04341493">NCT04341493</a>	Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19	Mexico	Y	N	Drug Repurposing	Nitazoxanide	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04315480">NCT04315480</a>	Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis	Italy	N	N	Drug Repurposing	Tocilizumab	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04346446">NCT04346446</a>	Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients	India	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04346628">NCT04346628</a>	Oral Favipiravir Compared to Standard Supportive Care in Subjects With Mild COVID-19	United States	Y	N	Drug Repurposing	Favipiravir	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04362059">NCT04362059</a>	A Clinical Trial of Nebulized Bovactant (Alveofact ) for the Treatment of Moderate to Severe COVID-19	United Kingdom	Y	N	Drug Repurposing	Bovactant	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04338906">NCT04338906</a>	Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19	Germany	Y	N	Drug Repurposing	Camostat	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04325893">NCT04325893</a>	Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease	France	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Mortality	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04344535">NCT04344535</a>	Convalescent Plasma vs. Standard Plasma for COVID-19	United States	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04359901">NCT04359901</a>	Sarilumab for Patients With Moderate COVID-19 Disease: A Randomized Controlled Trial With a Play-The-Winner Design	United States	Y	N	Drug Repurposing	Sarilumab	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04361253">NCT04361253</a>	Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy	United States	Y	N	Cell/Blood based	Convalescent plasma	Efficacy - WHO scale	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04322123">NCT04322123</a>	Safety and Efficacy of Hydroxychloroquine Associated With Azythromycin in SARS-Cov-2 Virus (COVID-19)	Brazil	Y	Y	Drug Repurposing	Hydroxychloroquine, Azithromycin	Efficacy - WHO scale	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04337918">NCT04337918</a>	Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection	Canada	N	N	Shelved drug or NME	Nitric Oxide Releasing Solution	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP), Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04326036">NCT04326036</a>	Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection	United States	N	N	Cell/Blood based	ND:Stem cells	Safety	Other	
<a href="https://ClinicalTrials.gov/show/NCT04344548">NCT04344548</a>	Phase I / II Clinical Study of Immunotherapy Based on Adoptive Cell Transfer as a Therapeutic Alternative for Patients With COVID-19 in Colombia	Colombia	N	N	Cell/Blood based	ND:NK-cells	Safety	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04322396">NCT04322396</a>	Proactive Prophylaxis With Azithromycin and Chloroquine in Hospitalized Patients With COVID-19	Denmark	Y	Y	Drug Repurposing	Azithromycin, Hydroxychloroquine	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04347031">NCT04347031</a>	An Open Randomized Study of the Effectiveness of Mefloquine for the Treatment of Patients With COVID19	Russian Federation	Y	Y	Drug Repurposing	Mefloquine, Hydroxychloroquine, Azithromycin, Tocilizumab	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04346693">NCT04346693</a>	An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19	Russian Federation	Y	N	Shelved drug or NME	Dalargin	Efficacy - Viral load	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04341610">NCT04341610</a>	ASC Therapy for Patients With Severe Respiratory COVID-19	Denmark	Y	N	Cell/Blood based	ND:Stem cells	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04345289">NCT04345289</a>	Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia	Denmark	Y	Y	Drug Repurposing, Cell/Blood based	ND:Convalescent plasma, Sarilumab, Baricitinib, Hydroxychloroquine	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04293887">NCT04293887</a>	Efficacy and Safety of IFN-a2 in the Treatment of Novel Coronavirus Patients	China	Y	N	Drug Repurposing	Interferon alpha-1b	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04348370">NCT04348370</a>	BCG Vaccine for Health Care Workers as Defense Against COVID 19	United States	Y	N	Vaccine	BCG Vaccine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04353037">NCT04353037</a>	PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine	United States	Y	Y	Drug Repurposing	Hydroxychloroquine	Efficacy - Other efficacy	Exposed individuals (family members, HCP), Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04283461">NCT04283461</a>	Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis SARS CoV-2 Infection (COVID-19)	United States	N	Y	Vaccine	ND:Vaccine	Safety	General population	
<a href="https://ClinicalTrials.gov/show/NCT04343729">NCT04343729</a>	Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19	Brazil	Y	N	Drug Repurposing	Methylprednisolone	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04338802">NCT04338802</a>	Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19	China	Y	N	Drug Repurposing	Nintedanib	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04326426">NCT04326426</a>	ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection	United States	Y	N	Shelved drug or NME	Tradipitant	Efficacy - Clinical improvement (except WHO scale)	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04280224">NCT04280224</a>	NK Cells Treatment for COVID-19	China	Y	N	Cell/Blood based	ND:T-cells	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04269525">NCT04269525</a>	Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia	China	N	N	Cell/Blood based	ND:Stem cells	Efficacy - Oxygen parameters	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04261907">NCT04261907</a>	Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection	China	Y	N	Drug Repurposing, Shelved drug or NME	ASC09/ritonavir	Efficacy - Oxygen parameters	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04299152">NCT04299152</a>	Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19	China	Y	N	Cell/Blood based	ND:Stem cells	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04306393">NCT04306393</a>	Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19	United States	Y	N	Drug Repurposing	Nitric oxide	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04361552">NCT04361552</a>	Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)	United States	Y	N	Drug Repurposing	Tocilizumab	Efficacy - Mortality	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04340557">NCT04340557</a>	Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection	United States	Y	N	Drug Repurposing	Losartan	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04322773">NCT04322773</a>	Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure	Denmark	Y	Y	Drug Repurposing	Tocilizumab, Sarilumab	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04346329">NCT04346329</a>	Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19	Colombia	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04336410">NCT04336410</a>	Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers	United States	N	N	Vaccine	INO-4800	Safety	General population	
<a href="https://ClinicalTrials.gov/show/NCT04264533">NCT04264533</a>	Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia	China	Y	N	Drug Repurposing	Ascorbic acid	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04323527">NCT04323527</a>	Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2	Brazil	Y	N	Drug Repurposing	Chloroquine	Efficacy - Mortality	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04349371">NCT04349371</a>	Saved From COVID-19	United States	Y	N	Drug Repurposing	Chloroquine	Efficacy - Other efficacy	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04322682">NCT04322682</a>	Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)	Canada	Y	N	Drug Repurposing	Colchicine	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04350281">NCT04350281</a>	Double Therapy With IFN-beta 1b and Hydroxychloroquine	Hong Kong	Y	N	Drug Repurposing	Interferon beta-1b	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04275245">NCT04275245</a>	Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia	China	N	N	Shelved drug or NME	Meplazumab	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04355052">NCT04355052</a>	Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to "no Treatment" in SARS CoV 2 Virus	Israel	Y	Y	Drug Repurposing	Azithromycin, Camostat	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04341727">NCT04341727</a>	Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection	United States	Y	Y	Drug Repurposing	Hydroxychloroquine, Azithromycin, Chloroquine	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04342728">NCT04342728</a>	Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation	United States	Y	N	Drug Repurposing, Other	Ascorbic Acid, ND:Zinc Gluconate	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04356833">NCT04356833</a>	Nebulised Rt-PA for ARDS Due to COVID-19	United Kingdom	N	N	Shelved drug or NME	Nebulised Rt-PA	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04328467">NCT04328467</a>	Pre-exposure Prophylaxis for SARS-Coronavirus-2	United States	Y	Y	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	General population	
<a href="https://ClinicalTrials.gov/show/NCT04333251">NCT04333251</a>	Study Testing Convalescent Plasma vs Best Supportive Care	United States	Y	N	Cell/Blood based	ND:Convalescent plasma	Efficacy - Oxygen parameters	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04316377">NCT04316377</a>	Norwegian Coronavirus Disease 2019 Study	Norway	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04276688">NCT04276688</a>	Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment	Hong Kong	Y	Y	Drug Repurposing	Ribavirin, Interferon beta-1b	Efficacy - Viral load	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT03852537">NCT03852537</a>	Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia	United States	Y	N	Drug Repurposing	Methylprednisolone	Other	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04308668">NCT04308668</a>	Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2	United States	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	General population	
<a href="https://ClinicalTrials.gov/show/NCT04276987">NCT04276987</a>	A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia	China	N	N	Cell/Blood based	ND:Stem cells	Safety	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04363437">NCT04363437</a>	the COMBAT-COVID-19 Pilot Study	United States	Y	N	Drug Repurposing	Colchicine	Efficacy - Oxygen parameters	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04363840">NCT04363840</a>	The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations	United States	Y	N	Drug Repurposing	Aspirin, Vitamin D	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04363502">NCT04363502</a>	Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection	United States	Y	N	Shelved drug or NME	Clazakizumab	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT03648372">NCT03648372</a>	A Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of TAK-981 in Adult Participants With Advanced or Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies and in a Subset With Coronavirus Disease 2019 (COVID-19)	United States	N	N	Shelved drug or NME	TAK-981	Safety	Other	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001417-21/BE">2020-001417-21</a>	An open label single center randomized controlled trial to evaluate the effect of hydroxychloroquine on viral shedding in mild COVID-19	Belgium	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001770-30/BE">2020-001770-30</a>	COVID 19: Experimental use of tocilizumab (Roactemra&reg;) in severe SARS-CoV-2 related pneumonia.	Belgium	Y	N	Drug Repurposing	Tocilizumab	Efficacy - WHO scale	Severe Cases	
<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001391-15/IE">2020-001391-15</a>	A randomized double-blind placebo-controlled trial of intravenous plasma-purified alpha-1 antitrypsin for severe COVID-19 illness.	Ireland	N	N	Cell/Blood based	ND:Alpha-1 antitrypsin	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04363346">NCT04363346</a>	Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia	United States	N	N	Shelved drug or NME	FT516	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04364022">NCT04364022</a>	Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland	Switzerland	Y	Y	Drug Repurposing	Hydroxychloroquine, Lopinavir/ritonavir	Efficacy - Other efficacy	Exposed individuals (family members, HCP)	
<a href="https://ClinicalTrials.gov/show/NCT04362813">NCT04362813</a>	Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia	United States	Y	N	Drug Repurposing	Canakinumab	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04363372">NCT04363372</a>	A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19	United Kingdom	Y	N	Shelved drug or NME	MRx-4DP0004	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04363866">NCT04363866</a>	A Pilot Study to Assess Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19)	United States	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - WHO scale	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04363216">NCT04363216</a>	Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment	United States	Y	N	Drug Repurposing	Ascorbic Acid	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04363814">NCT04363814</a>	Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection	United States	Y	N	Shelved drug or NME	Bactek-R	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04331899">NCT04331899</a>	Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19	United States	Y	N	Shelved drug or NME	Peg-Interferon lambda-1a	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04363736">NCT04363736</a>	A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia	United States	Y	N	Drug Repurposing	Tocilizumab	Efficacy - Other efficacy	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04363060">NCT04363060</a>	Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit	France	Y	N	Drug Repurposing	Azithromycin, Amoxicillin/clavulanate	Efficacy - Viral load	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04363203">NCT04363203</a>	VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL)	United States	Y	Y	Drug Repurposing	Hydroxychloroquine, Azithromycin	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Other	
<a href="https://ClinicalTrials.gov/show/NCT04363853">NCT04363853</a>	Tocilizumab Treatment in Patients With COVID-19	Mexico	N	N	Drug Repurposing	Tocilizumab	Efficacy - Other efficacy	Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04364009">NCT04364009</a>	Anakinra for COVID-19 Respiratory Symptoms	France	Y	N	Drug Repurposing	Anakinra	Efficacy - Clinical improvement (except WHO scale)	Mild/Moderate Cases, Severe Cases	
<a href="https://ClinicalTrials.gov/show/NCT04363827">NCT04363827</a>	Protect: A Randomized Study With Hydroxychloroquine Versus Observational Support for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19)	Italy	Y	Y	Drug Repurposing	Hydroxychloroquine	Efficacy - Other efficacy	Mild/Moderate Cases	
<a href="https://ClinicalTrials.gov/show/NCT04363450">NCT04363450</a>	Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP)	United States	Y	N	Drug Repurposing	Hydroxychloroquine	Efficacy - Infection rate (prevention)	Exposed individuals (family members, HCP)	

